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ABSTRACT
Entamoeba histolytica is a protozoan parasite that causes amoebic colitis and liver
abscess in approximately 90 million people each year, resulting in 50,000-100,000
fatalities. Even though Entamoeba poses a significant public health problem worldwide,
research dedicated to understanding the biology of this unique protozoan has been
limited. This amitochondriate parasite lacks many essential biosynthesis pathways
including the tricarboxylic acid (TCA) cycle and oxidative phosphorylation. As a result,
substrate level phosphorylation plays a necessary role in ATP production. Unlike the
standard glycolytic pathway, E. histolytica glycolysis requires pyrophosphate (PPi) by
replacing ATP–dependent phosphofructokinase and pyruvate kinase with PPi–dependent
phosphofructokinase and phosphate pyruvate dikinase.
E. histolytica infects and colonizes the human colon where glucose is limited and
short chain fatty acids (acetate, propionate, and butyrate) are plentiful. Acetate is also a
major end product that is excreted when E. histolytica is grown axenically on glucose.
Acetate has been demonstrated to act as carbon and energy source for cellular growth in
other organisms, acetogenesis can regenerate NAD+, recycle coenzyme A, and produce
ATP when the TCA cycle or oxidative phosphorylation does not operate or when the
carbon flux into the cell exceed its capacity.
In E. histolytica, acetate can be generated by acetate kinase (ACK) and ADP–
forming acetyl–CoA synthetase (ACD). ACK converts acetyl phosphate +
orthophosphate (Pi) to acetate + PPi. Previous biochemical and kinetic characterization of
III
recombinant ACK showed that it strongly prefers the acetate/PPi-forming direction. We
hypothesized that ACK may function to supply PPi for the PPi oriented glycolytic
pathway in E. histolytica. Recombinant ACD displayed high activity in both directions of
the reaction to convert acetyl-CoA + orthophosphate + ADP to acetate + ATP + CoA.
ACD may function to extend the glycolytic pathway to increase ATP production by 40%
per molecule of glucose, or in the alternative direction to convert acetate to acetyl-CoA to
meet the cell’s metabolic needs.
Using reverse genetics, an Ehacd silenced strain displayed a growth defect in
normal high glucose media, while Ehack silenced cells showed enhance growth in
medium without added tryptone and glucose. The presence of acetate and butyrate
showed no effect on E. histolytica growth in the absence of glucose regardless of ACK or
ACD activity. The presence of propionate, however, improved E. histolytica growth and
impaired growth of the Ehacd silenced strain implicated ACD as the cause of this
improvement. Our data suggest ACD plays a role in increasing ATP production during
growth on glucose and utilization of propionate as a growth substrate. Our data do not
support the previously hypothesized role for ACK but instead suggest it possesses a novel
function.
The basis for E. histolytica ACK’s divergence from all other ACKs in phosphoryl
substrate utilization was also explored. Currently, E. histolytica ACK is the only known
ACK that uses pyrophosphate (PPi) or inorganic phosphate (Pi) as the phosphoryl donor
or acceptor. All other known ACKs utilize ATP or ADP. In silico structural comparison
and modeling of E. histolytica ACK against other ACKs identified structural differences
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that could affect substrate binding and selection. ACK variants were generated to test
these predictions. Inhibition and structural activity relationship studies revealed an
occlusion in the ADENOSINE motif of E. histolytica ACK reduced ATP and ADP
binding affinity. However, alterations to alleviate the constriction did not confer activity
with ATP or ADP. Our results suggest controlling access of the adenosine pocket
influences phosphoryl substrate binding but is not the sole determinant of enzyme
activity.
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1CHAPTER I
LITERATURE REVIEW
INTRODUCTION: 
Entamoeba histolytica, an amitochondriate parasite, infects and resides within the 
human colon. Due to its reductive metabolism and lack of oxidative phosphorylation, 
glycolysis is widely accepted as the main pathway of energy and carbon metabolism. 
During E. histolytica growth, acetate and ethanol are the two major end-products that are 
always produced. Moreover, acetate represents one of the most abundant short chain fatty 
acid found in the human large intestine from fermentative metabolism by the colon flora. 
Thus, acetate production and utilization by E. histolytica is of great interest. Two enzymes 
identified in E. histolytica that produce acetate are acetate kinase (EhACK) and ADP-
forming acetyl CoA synthetase (EhACD) and are the subject of this dissertation research.
Acetate kinase (ACK) is widespread in bacteria, but is found in just one genus of 
archaea and a few eukaryotic microbes. ACK interconverts acetate and acetyl phosphate 
using ATP and ADP. Even though EhACK can interconvert acetate and acetyl phosphate 
in vitro, kinetic analysis indicates its physiological direction is likely limited to the 
acetate-forming direction due to its considerable preference for this direction. 
Additionally, EhACK uses pyrophosphate (PPi) and inorganic phosphate (Pi) instead of 
ATP and ADP for catalysis. Currently, EhACK is the only known ACK to show this 
phosphoryl substrate selectivity.
2Acetate metabolism is a common process in many organisms. Acetate production
and utilization have been shown to have a significant role in growth. Moreover, acetate
has also been reported to be involved in regulating pathogenesis, histone acetylation,
gene expression and motility (7, 11-13, 58-59, 80).
In bacteria ACK partners with phosphotransacetylase in a reversible pathway to
convert acetyl-CoA to acetate to produce ATP and recycle coenzyme A. Conversely,
AMP-forming acetyl-CoA synthetase (ACS) functions unidirectionally to activate acetate
into acetyl-CoA. E. histolytica lacks ACS and instead has the bidirectional ACD.
Although acetate is a primary metabolic product during E. histolytica growth on glucose,
the majority of E. histolytica infection resides within the glucose-limited environment of
the large intestine. This presents a need to further explore alternative metabolic pathways
within this parasite. EhACK and EhACD may present two such pathways for energy
conservation and acetate activation that allow adaptability for survival and growth by E.
histolytica in the acetate rich environment of the large intestine.
The purpose of this review is to provide an overview of the significant impact of
acetate and introduce acetate metabolism pathways. E. histolytica metabolism is
discussed with a focus on its central carbon metabolism. Lastly, a history of acetate
kinase is also provided.
3ACETATE METABOLISM:
Acetate is a common short chain fatty acid (SCFA) metabolite in many
organisms. In the human colon, SCFAs compose >60% of the anion concentration (110-
120 mM) (1), mainly as acetate, propionate and butyrate with a relative molar mass ratio
of 57:22:21 (2), respectively. These SCFAs are rapidly absorbed by the colonic mucosa (1)
with less than 5% SCFA produced by bacteria found in feces (3). Butyrate acts as the main
energy source for colonocytes (3), propionate is readily absorb by the liver, and acetate
enters the peripheral circulation to be taken up by peripheral tissues (4).
Acetate can originate from a multitude of sources. This SCFA can be obtained
from the diet, generated by the liver, or produced locally and intracellularly through
enzymatic reactions. The main source of acetate within the human body arises from
fermentation by commensal gut microbiota (9, 10). Acetate assimilation as an alternative
carbon source has been demonstrated in bacteria cells in limited nutrient environments (1).
Acetate excretion, on the other hand, is often observed to fulfill a need to generate
additional ATP and regenerate NAD+ and Coenzyme A when oxidative phosphorylation
is nonfunctional or in circumstances where the carbon flux exceeds the capacity of the
central carbon metabolic pathways (1). As a result, acetate production is often considered
to be an “overflow” metabolic pathway.
Acetate from fermentation within the colon can also traverse the blood brain
barrier and enter the brain (5). This results in an increase in hypothalamic acetate
concentration and can regulate appetite. Perry et al. (6) further showed increased
4production of acetate in the gut can lead to metabolic syndrome such as obesity and
diabetes. Acetate has also been linked to tumor growth (7, 8). Using [1,2-13C] acetate,
Mashimoto et al. (8) have shown that as much as 50% of TCA cycle intermediates are
acetate-derived in brain tumor cells even when glucose is abundant. More strikingly, they
observed a 40% increase in acetate-derived carbon incorporated into TCA cycle
intermediates in tumor cells compared to non-tumor cells, illustrating the significant role
of acetate in meeting the high biosynthetic and bioenergetics demands of tumor cells.
Additionally, acetate has been reported to also influence growth; motility in Escharichia
coli and Salmonella enterica; histone acetylation in yeast, mice, and human; pathogenesis
E. coli; and pathogenic gene regulation S. enterica (7, 11-13, 58-59, 80). This illustrates acetate
metabolism not only may affect the host but also the surrounding microbiome.
Acetate metabolism in bacteria
Acetate metabolism is well studied in bacteria, most notably in Escherichia coli.
Acetogenesis in E. coli takes place through either an acetate kinase (ACK; EC 2.3.1.8)(14)
– phosphotransacetylase (PTA; EC 2.7.2.1)(15) pathway or by pyruvate dehydrogenase
(ubiquinone) (POXB; EC 1.2.5.1) (1, 11). PTA catalyzes the reversible conversion of
acetyl-CoA to acetyl phosphate and releases coenzyme A (16) (Eq. 1). Subsequently, ACK
transfers the phosphate from acetyl phosphate to ADP to produce acetate and ATP in a
reversible reaction (Eq. 2). Acetate can also be generated by a pyruvate decarboxylating
enzyme, POXB, which decarboxylates pyruvate to acetate, releasing carbon dioxide and
reducing ubiquinone (Eq. 3) (1, 17). Dittrich et al. (11) found ACK-PTA was the main
5acetate producing pathway during exponential growth and POXB dominated during
stationary phase.
In certain lactobacilli, Pediococcus, and Streptococcus, a second type of pyruvate
oxidase (POX-AP; EC 1.2.3.3) is present to convert pyruvate to acetyl phosphate instead
of acetate (Eq. 4) (1). Other enzymes that produce acetyl phosphate are xylulose-5-
phosphate/fructose-6-phosphate phosphoketolase (Eq. 5), sulfoacetaldehyde
acetyltransferase (Eq. 6), and glycine reductase (Eq. 7). Xylulose-5-phosphate
(X5P)/fructose-6-phosphate (F6P) phosphoketolase (XFP; EC 4.1.2.9, EC 4.1.2.22)
cleaves X5P/F6P into acetyl phosphate and glyceraldehyde-3-phosphate (G3P)/erythose-
4-phosphate (E4P). This phosphoketolase is found in heterofermentative lactobacilli and
organisms such as Acetobacter xylinum, Butyrivibrio fibrisolvens, Fibrobacter
succinogenes and Fibrobacter intestinalis (1, 18).
Sulfoacetaldehyde acetyltransferase (XSC; EC 2.3.3.15) desulfonates
sulfoacetaldehyde into acetyl phosphate and sulfite. This enzyme has been identified
within several gram-positive bacteria and Proteobacteria (1, 19-21). Lastly, certain strictly
anaerobic gram-positive bacteria use glycine reductase (GR; EC 1.21.4.2) to convert
glycine (Gly), phosphate (Pi), and thioredoxin (Trx) to acetyl phosphate (AcP), ammonia,
thioredoxin sulfite (TrxS), and water (1). Several studies have shown these enzymes can
partner with ACK and/or PTA for anabolic metabolism or ATP production (22).
Eq. 1: PTA Acetyl-CoA + Pi acetyl phosphate + CoA
Eq. 2: ACK Acetyl phosphate + ADP acetate + ATP
6Eq. 3: POXB Pyruvate + ubiquinone + H2O acetate + CO2 + ubiquinol
Eq. 4: POX-AP Pyruvate + O2 + Pi acetyl phosphate + CO2 + H2O2
Eq. 5: XFP X5P/F6P + Pi acetyl phosphate + H2O + G3P/E4P
Eq. 6: XSC Sulfoacetaldehyde + Pi acetyl phosphate + sulfite
Eq. 7: GR Gly + Pi + Trx AcP + NH3 + TrxS + H2O
During conditions of nutrient depletion, cells can undergo a process termed the
“acetate switch” (Figure 1.1) (1). This is defined as when the cell shifts to utilizing acetate
as the alternative carbon source when glucose is absent and acetate is abundant. Acetate
activation can happen through either the ACK-PTA pathway or an AMP-forming acetyl-
CoA synthetase (ACS; EC 6.2.1.1), which converts acetate and ATP directly to acetyl-
CoA (Eq. 8) (12). Acetate assimilation occurs largely by ACS while dissimilation mainly
occurs through the ACK-PTA pathway. However, ACK-PTA reversibility can contribute
to acetate utilization (1, 12). Kumari et al. (12) demonstrated an acs deletion mutant grew
poorly at low acetate concentration, whereas ack and pta deletion mutants grew poorly at
high acetate concentrations and mutants with all three genes deleted did not grow at all
on acetate. This proves both pathways are used for acetate utilization but at different
environmental acetate concentrations.
Eq. 8: ACS Acetate + ATP + CoA acetyl-CoA+ PPi + AMP
7Figure 1.1: Schematic displaying the “acetate switch” during aerobic growth with
glucose as the sole carbon source. The arrow denotes the point of the “acetate switch”
where glucose becomes depleted and acetate production is switched to acetate utilization.
OD: optical density, ace: acetate; acCoA: acetyl-CoA; glc: glucose. Figure obtained and
modified from [1] with permission.
8ADP-forming acetyl-CoA synthetase (ACD; EC 6.2.1.13), converts acetyl-CoA
and ADP to acetate and ATP (Eq. 9). ACD activity was first described in the
thermophilic archaeon Pyrococcus furiosus (23), where it plays a crucial role in energy
conservation during sugar metabolism (24). Though not widespread, ACD has also been
identified in several archaea, such as Pyrococcus woesei, Desulfurococcus amylolyticus,
Hyperthermus butylicus, Thermococcus celer, Archaeoglobus fulgidus, Halobacterium
saccharovorum, Haloarcula marismortui, Methanococcus jannaschii, Pyrobaculum
aerophilum and Thermococcus kodakarensis (23, 25-29), and has also been identified in the
bacterium Chloroflexus aurantiancus (30). In prokaryotes, ACD belongs to the
superfamily of NDP-forming acyl-CoA synthetases.
Eq. 9: ACD Acetyl-CoA + ADP + Pi acetate + ATP + CoA
Besides carbon and energy metabolism, acetate production and utilization have
been linked to pathogenesis and motility in bacteria. Fukuda et al. (31) reported a
prolonged survival in mice infected with E. coli O157:H7 if the mice were colonized by
Bifidobacterium longum prior to infection. Data showed acetate production increased in
the presence of B. longum. In vitro experiments demonstrated acetate inhibited the
permeability of epithelial monolayer caused by E. coli O157 infection, preventing Shiga
toxin from E. coli O157:H7 translocation into the blood from the gut (31, 32).
In 2002, Lawhon et al. (13) found acetate activates BarA, a kinase that interacts
with SirA to initiate expression of the SPI-1 virulence genes in Salmonella enterica. This
suggests acetate may act as a signal for invasive gene expression in the intestine.
9Recently, Nakamura et al. (33) also reported acetate can inhibit Salmonella flagellar
motility. However, the mechanism of inhibition is still poorly understood but was
suggested to relate to regulation of the acetyl phosphate pool.
Acetyl-phosphate in signal transduction: Acetyl phosphate is a high energy compound,
possessing a greater ∆GO of hydrolysis (-43kJ/mol) than ATP (-30kJ/mol) (1). This is the
foundation of acetyl phosphate’s suggested role as a global signaling molecule (34, 35) by
phosphorylating members of the two components transduction system (2CTS) (1, 36-38).
2CTS consists of a histidine kinase (HK) being phosphorylated by ATP. HK-P in turn
phosphorylates the second component of the signaling system, the response regulator
(RR), to elicit a response.
An abundance of in vitro evidence demonstrated acetyl phosphate’s interaction
and autophosphorylation of the RR component of 2CTS pathway (Table 1.1). In vivo,
mounting evidence showed controlling the acetyl phosphate pool affects biofilm
formation, nitrogen assimilation, phosphate assimilation, flagella biogenesis, and
pathogenesis (1, 38, 39). Support for acetyl phosphate’s effect on flagellar motion was also
established. Wolfe et al. (40) reported exogenous acetate increased clockwise rotation of
E. coli flagella. Dailey and Berg (41) later presented evidence relating acetyl phosphate
synthesis to flagellar rotational direction. In 2007, Klein et al. (42) showed acetyl
phosphate can directly phosphorylate RR of the 2CTS based on the abundance of
intracellular acetyl phosphate in E. coli, further supporting acetyl phosphate proposed
role as a global signal.
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Organism HK RR
Pseudomonas aeruginosa AlgZ AlgR
Bordetella pertussis BvgS BvgA
Klebsiella pneumonia CitA CitB
Escherichia coli CheA CheY
Sinorhizobium meliloti CheA CheY1, Y2
Rhodobacter sphaeroides CheA CheY1, Y3-6
Helicobacter pylori CheV2
Bacillus subtilis ComP ComA
Shigella sonnei, E. coli CpxA CpxR
Streptococcus pyogenes CsrS CsrR
Spirulina platensis CyaC CyaC
E. coli DcuS DcuR
Sinorhizobium melilori FixL FixJ
Clostridium acetobutylicum KdpD KdpE
E. coli KdpD KdpE
Mycobacterium tuberculosis MprB MprA
E. coli NarX NarL
Bradyrhizobium japonicum NodV NodW
E. coli NRII (NtrB) NRI (NtrC)
E. coli EnvZ OmpR
E. coli PhoR PhoB
Salmonella enterica PhoQ PhoP
R. sphaeroides PrrB PrrA
Calothrix sp. strain PCC7601 CphA RcpA
Calothrix sp. strain PCC7601 CphB RcpB
Dictyostelium discoideum RdeA RegA
E. coli, S. enterica None RssB
S. enterica BarA SirA
Saccharomyces cerevisiae SLN1-YPD1 SSK1
Enterococcus faecium VanS VanR
Table 1.1: List of two-component response regulators from various microbes
previously shown to be influenced by acetyl phosphate. Figure obtained and modified
from [1] with permission.
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Acetate metabolism in eukaryotes
ACK, PTA and XFP were originally thought to function only in prokaryotes.
However, Blast searches have identified open reading frames for ACK, PTA and XFP in
a number of eukaryotic microbes (43). In Chlamydamonas, acetate was observed to be one
of the major metabolites excreted during anoxic growth (44). The same study also detected
an increase in ack1, ack2, pta1, and pta2 transcripts during anaerobic growth.  Consistent
with this finding, Yang et al.(45) showed disruption of ack1 and pta2 expression in
Chlamydamonas substantially reduced acetate production during anoxic growth. PTA
from the oomycete Phytophtora ramorum has also been identified and characterized (46).
Cryptococcus neoformans does not possess a PTA but does contains two XFPs and an
ACK (47, 48) . However, to date only one C. neoformans XFP has been biochemically and
kinetically characterized (48). In Entamoeba histolytica, ACK activity has been detected
both from recombinant enzyme and cell lysate (49, 50). However, distinct from other
ACKs, E. histolytica ACK (EhACK) is pyrophosphate dependent (Eq. 10).
Eq. 10: EhACK Acetate + PPi acetyl phosphate + Pi
ACS is also present in both prokaryotes and eukaryotes. As in prokaryotes,
eukaryotic ACS activates acetate into acetyl-CoA for energy conversion and anabolic
metabolism. Mammals express three isoforms of ACS. ACSS2 is localized in the nucleus
and cytosol while ACSS1 and ACSS3 are compartmentalized within the mitochondria (51,
52)
. Only ACSS1 and ACSS2 have been shown to be able to use acetate as a substrate.
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Currently, the classification of ACSS3 as an acetyl-CoA synthetase remains speculative
with no report of detectable enzymatic activity. Cytosolic ACS is usually found in the
liver and plays a role in generating acetyl-CoA for fatty acid and cholesterol biogenesis
(53)
. Mitochondrial ACS is found in heart and skeletal muscle (54). Acetyl-CoA generated
by mitochondrial ACS is used for energy metabolism via oxidative phosphorylation. As
such, ACS activity has been connected to tumor growth and metabolic syndrome such as
obesity and diabetes (6-8).
In other eukaryotes, two isoforms of ACS generally exist (ACS1 and ACS2) (55).
In Candida albicans, ACS2 is crucial for survival and growth on most carbon sources,
including glucose (56). ACS has also been identified in Trypanosoma and has a vital role
in fatty acid biosynthesis in procyclic Trypanosoma brucei (57). Additionally, ACS
involvement in histone acetylation has been reported. Eisenberg et al. (58) detected
activation of ACS2 during cytosolic accumulation of acetate, triggering histone
acetylation and reducing autophagy in yeast. A similar relationship between ACS and
acetylation has been observed in both mice and human (7, 59, 60).
Other acetate producing pathways in eukaryotes include acetylaldehyde
dehydrogenase (ALDH; EC 1.2.1.5), acetate:succinate CoA transferase (ASCT; EC
2.8.3.18), ADP-forming acetyl-CoA synthetase, and acetyl–CoA hydrolase (ACH; EC
3.1.2.1). ALDH converts acetylaldehyde to acetate with the reduction of NADP+ (Eq.
11). In Saccharomyces cereviseae, ALDH partners with pyruvate decarboxylase (PDC;
EC 4.1.1.1) and ACS to form a pyruvate dehydrogenase bypass for the conversion of
13
pyruvate into acetyl-CoA(61, 62). Saint-Prix et al. (61) demonstrated that deletion of the
ALDH gene decreased acetate production and reduced growth in Saccharomyces.
ACH is responsible for the interconversion of acetyl-CoA and acetate (Eq. 12). In
Candida and Saccharomyces, ACH contributes to the utilization of acetate as an
alternative carbon source (56, 63). ACH can also function in the acetate-forming direction
to shuttle acetyl-CoA out of the mitochondria in Saccharomyces by converting acetyl-
CoA to acetate for transport (64). In the cytosol, acetate can be converted back into acetyl-
CoA by ACS.
Of the acetate producing enzymes in eukaryotes, only two have been identified in
parasites: ASCT and ACD. ASCT is a CoA transferase which produces acetate in a
succinate dependent manner. ASCT transfers the CoA moiety from acetyl-CoA to
succinate, generating succinyl-CoA and acetate (Eq. 13). ASCT can work with succinyl-
CoA synthetase (SCS) to recycle CoA, regenerate succinate and produce ATP from ADP
(65)
. This ASCT-SCS cycle has been identified in Tritrichomonas foetus, Trichomonas
vaginalis, Faschiola hepatica, Trypanosoma brucei, Leishmania mexicana, Leishmania
infantum, Phytomonas and Neocallimastix (66-72).
Eq. 11: ALDH Acetylaldehyde + H2O + NADP+ acetate + NADPH
Eq. 12: ACH Acetyl-CoA + H2O acetate + CoA
Eq. 13: ASCT Acetyl-CoA + succinate succinyl-CoA + acetate
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ACD exists in all three domains of life but is not widespread. ACD was first
observed in Entamoeba histolytica (73) and later observed in Giardia lamblia (74).
Recombinant ACD has been purified from E. histolytica and G. lamblia and
biochemically characterized (75, 76). Sequence analyses have also identified ACD in
Blastocystis hominis and several Plasmodium spp (77, 78).
Overall, an array of acetate producing pathways are available (Figure 1.2),
reflecting how acetate metabolism adds adaptability for survival of an organism. These
pathways also demonstrate acetate’s impact beyond carbon and energy metabolism.
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Figure 1.2: Common acetate metabolic pathways. HK: histidine kinase; HK-P:
phosphorylated histidine kinase; RR: response regulator; RR-P: phosphorylated response
regulator; ACK: acetate kinase; GR: glycine reductase; XFP: xylulose-5-
phosphate/fructose-6-phosphate phosphoketolase; XSC: sulfoacetaldehyde
acetyltransferase; POX-AP; pyruvate oxidase (acetyl phosphate forming); POXB:
pyruvate oxidase; ACD: ADP-forming acetyl-CoA synthetase; PDC; pyruvate
dehydrogenase; PFOR: pyruvate ferredoxin oxidoreductase; ACS: AMP-forming acetyl-
CoA synthetase; ASCT: acetate: succinate CoA transferase; ACH: acetyl-CoA hydrolase;
ALDH: acetylaldehyde dehydrogenase; PTA: phosphotransacetylase.
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Entamoeba Histolytica:
Entamoeba Histolytica is a microaerophilic protozoan responsible for amebiasis, a 
disease that causes amebic colitis and liver abscess in humans. Even though Fedor Losch 
first described intestinal amebiasis in 1875, E. histolytica was not identified as the 
causative agent until 30 years later by Fritz Schaudinn (79). Amebiasis is prevalent in 
developing areas of the world due to poor sanitation. High risk areas include India, 
Africa, Bangladesh, Thailand, Mexico, and parts of South and Central America. 
Annually, 90 million people develop symptomatic amebiasis, leading to 50,000-100,000 
deaths (80).
E. histolytica is a nonflagellated, pseudopod forming parasite that infects humans 
and possibly other primates as natural hosts (81). As the name suggests, this parasite 
causes proteolysis, tissues lysis, and host cell apoptosis (82). Symptoms of amebic colitis 
include abdominal pain, watery or bloody diarrhea, fever and weight loss that can persist 
for several weeks. Extraintestinal infection can also develop, often leading to liver 
infection which includes tissue destruction and abscess. In rare cases, E. histolytica can 
end up in the lung, heart, brain, or other organs. If untreated, extraintestinal infection will 
lead to death.
E. histolytica exists in two life stages: cyst and trophozoite. The cyst represents 
the infectious form and ranges from 10-16 µm in size, whereas the trophozoite is the 
motile form and is 20-40 µm in size (83). E. histolytica infection is passed through an oral-
fecal route. Amebiasis is initiated when cysts are ingested. After ingestion, the cysts will
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travel through the host’s digestive tract and begin excystation after reaching the small
intestine. During excystation, cysts differentiate into trophozoites and migrate toward the
large intestine for colonization (Figure 1.3).
In most cases, the infection remains asymptomatic and new cysts are released
within the host’s stool to continue the cycle. Cyst formation provides a survival
mechanism for Entamoeba in adverse environmental conditions. The Entamoeba cyst
wall is characterized by a mix of chitin and protein (84) and provides environmental
resistance. The stimuli and molecular mechanism of encystation in E. histolytica remain
largely undefined due to lack of an in vitro system to stimulate E. histolytica’s stage
differentiation. However, Entamoeba invadens, a relative of E. histolytica which causes
similar invasive infection in reptiles, is used as a model system to study encystation. In E.
invadens, stimuli involved in cyst formation include glucose starvation (85), osmotic shock
(86, 87)
, autocrine catecholamine(88, 89), and cholesteryl sulfate (90). Heat shock protein (91),
chitin metabolism (92, 93), and enolase (94, 95) have also been shown to play a role in the
process of encystation.
In some infected individuals, E. histolytica trophozoites will invade the intestinal
mucosa, causing amoebic colitis. The parasites can then enter the bloodstream and
migrate beyond the intestine to infect other organs, most commonly the liver (80). The host
employs a number of defense mechanism to fight against Entamoeba infection.
Unfortunately though, the parasite has developed several methods to evade host
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Figure 1.3: Entamoeba histolytica life cycle. A: E. histolytica infection route in humans.
Infection proceeds through an oral-fecal route. Cysts differentiate into trophozoites in the
small intestine to colonize within the colon. Cysts and trophozoites can be expunged from
the host to continue its life cycle or infect extraintestinal organs (red arrows). B: E.
histolytica differentiation cycle and life stages. Figure obtained and modified from the
CDC website(80).
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immunity. Stomach acid acts as the first line of defense against E. histolytica. Strong acid
protects against enteropathogens by lysing acid-sensitive organisms. However, the E.
histolytica cyst cell wall allows the parasite to survive within this extreme environment.
Other immune evasion mechanisms and virulence factors deployed by the
trophozoite include Gal/GalNac lectins, cysteine protease, amoebapore, and peroxidoxin.
Both Gal/GalNac lectin and cysteine protease have been demonstrated as crucial in E.
histolytica pathogenesis and invasion (96-98). Gal/GalNac lectin enables E. histolytica to
adhere to the intestinal mucus layer (96, 99, 100). The mucus layer acts as the second layer of
innate immunity. E. histolytica overcomes this by secreting cysteine protease, causing
destruction of the intestinal mucus layer. Cysteine proteases have also been reported to
degrade complement immune factors (101).
Gal/GalNac lectin also shares similarity and cross-reactivity with CD59, allowing
the parasite to circumvent some of the host complement immunity (102). Nitric oxide and
reactive oxygen species released by host neutrophils and macrophages are also utilized to
defend against infection. However, E. histolytica kills neutrophils far more effectively
(103) and express peroxidoxin, a surface protein, to provide antioxidant properties against
oxidative defense (104). Lastly, E. histolytica secretes amoebapore, a pore forming peptide
that causes cytolysis of host and bacteria cells (105-108). Zhang et al. (109) have shown
amoebapore expression is required for full virulence of E. histolytica.
Treatment for amebiasis consist of a combination of drugs or surgical procedure.
Luminal infections can be treated with oral drugs such as diloxanide furnoate,
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paromomycin, and iodoquinol (82). The drug of choice to treat invasive infection is
metronidazole. Treatment is often followed by luminal drugs to prevent relapse.
Tinidazol treats symptomatic infection as an alternative to metronidazol and has been
shown to have a higher cure rate (110). Percutaneous drainage can also be employ as a
therapy for liver infection (111).
Metabolism
E. histolytica contains a unique metabolic system. It lacks many major
components commonly present in other eukaryotes. E. histolytica is unable to synthesize
nucleotide, fatty acids, or amino acids except for serine and cysteine (112). Thus,
scavenging plays a critical role in this organism’s ability to overcome and accommodate
its metabolic needs (113).
E. histolytica is capable of engulfing extracellular components through multiple
means. Phagocytosis allows trophozoites to consume bacteria and solid debris during
colonization of the host intestinal mucosa. Along with nutrient acquisition, phagocytosis
has been associated with virulence (114, 115). Alternatively, macropinocytosis allows E.
hisotlytica to uptake fluid and nutrients from the environment (116). In a recent report, E.
histolytica was also shown to ingest host cells in fragments in a process termed
trogocytosis instead of engulfing them whole. This ceases when the host cell dies (117).
E. histolytica also lacks mitochondria, a tricarboxylic acid cycle and a functional
pentose phosphate pathway (118). Instead, a closely related mitochondrial organelle called
the mitosome is present. A mitosome is a metabolically specialized organelle that is
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found in many pathogens occupying low oxygen environments. The central role of the
mitosome in E. histolytica still remains undefined. However, several studies have
indicated E. histolytica’s mitosome may be involved in iron-sulfur cluster formation and
sulfate activation pathways (119-121).
Due to the absence of a mitochondrion and oxidative phosphorylation, E.
histolytica ATP synthesis is primarily restricted to substrate level phosphorylation with
glycolysis as the main ATP-generating pathway (118). Instead of having an ATP-driven
phosphofructokinase, E. histolytica uses a PPi–dependent phosphofructokinase (PPi–
PFK) to convert fructose-6-phosphate to fructose-1, 6-bisphosphate (122).  Similarly, a
PPi-dependent pyruvate phosphate dikinase (PPDK) replaces pyruvate kinase in the final
step of glycolysis (Figure 1.4) (123).
Another deviation in this parasite’s glycolytic pathway is the absence of pyruvate
dehydrogenase. In its place, pyruvate:ferredoxin oxidoreductase (PFOR) extends
glycolysis by catalyzing the oxidative decarboxylation of pyruvate to acetyl-CoA using
ferredoxin as an electron acceptor (73). Acetate and ATP are then released from acetyl–
CoA, ADP and Pi by the catalytic activity of ADP–forming acetyl–CoA synthetase
(ACD). Parallel to ACD, the bifunctional aldehyde-alcohol dehydrogenase (ADHE)
converts acetyl–CoA to ethanol (EtOH) by reducing two NADH molecules per EtOH
produced (Figure 1.4).
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Figure 1.4: E. histolytica extended glycolytic pathway. PPi-PFK: PPi-dependent
phosphofructokinase; PPDK: PPi-dependent pyruvate phosphate dikinase; PFOR:
pyruvate: ferredoxin oxidoreductase; ADHE: bifunctional alcohol-aldehyde
dehydrogenase; ACD: ADP-forming acetyl-CoA synthetase; Fd: ferredoxin. Dashed
arrows represent conversions carried out through several enzymatic steps.
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In many organisms, glycogen metabolism contributes substantially to survival and
energy metabolism during unfavorable conditions (124). Electron microscopy revealed E.
histolytica possesses dense glycogen granules (125). Later NMR analyses showed a high
concentration of glycogen in E. histolytica cell extract (126, 127). Accordingly, in vitro
analysis demonstrated active glycogen degradation activity from E. histolytica
homogenate (128). A recent report by Pineda et al. (129) indicates glycogen degradation can
sustain cell viability for up to two hours before death occurs, suggesting glycogen plays a
possible role as a source of reserve carbon in E. histolytica.
Amino acids catabolism has also been suggested to generate ATP in E.
hisotlytica. In 1995, Zuo and Coombs (130) found that E. histolytica consumes five amino
acids at a marked level: asparagine, arginine, leucine, threonine, and phenylalanine.
Subsequently, genome sequences identified several enzymes capable of degrading amino
acids such as asparagine, aspartate, methionine, threonine, and tryptophan to pyruvate or
2–oxobutanoate (118). In addition to pyruvate, PFOR can also utilize 2–oxobutanoate to
produce propionyl–CoA, which can then be used by ACD as a substrate for the
generation of ATP and propionate (Figure 1.5) (118). However, a recent study comparing
the ATP level after incubating E. histolytica for two hours in PBS with and without an
amino acid source concluded that amino acids do not contribute to E. histolytica ATP
generation (129). However, the long term influence of amino acids on ATP production
remains unresolved.
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Figure 1.5: Predicted amino acid degradation pathways in E. histolytica. Several
amino acids can be converted into useable substrate for pyruvate: ferredoxin
oxidoreductase and ADP-forming acetyl-CoA synthetase for the generation of ATP.
Figure obtained and modified with permission from [118].
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Ultimately, acetate and ethanol are excreted as major end–products of energy
metabolism in E. histolytica (73, 131). Initial analysis indicated ethanol as the favorable
product from monoxenic amoebas in anaerobic condition (131). When exposed to oxidative
stress however, acetate was shown to be the major end–product from axenic culture (73).
Pineda et al. (20 13) validated this finding and presented evidence pointing to ADHE
inhibition by reactive oxygen species as the cause for the acetate shift.
Besides ACD, E. histolytica can also generate acetate from cysteine synthase and
ACK (Figure 1.6). Cysteine synthase converts O-acetyl-L-serine to acetate and L-
cysteine(132). Multiple studies have shown the importance of cysteine synthesis in cellular
attachment, motility, growth and oxidative stress tolerance in E. histolytica (133-137).
E. histolytica ACK (EhACK) is PPi-dependent and primarily functions in the
acetate/PPi -producing direction (49, 50). The physiological role of this enzyme still remains
a mystery. One hypothesis is EhACK may act to supply PPi for the PPi-oriented
glycolytic pathway in E. histolytica. To date though, a source of acetyl phosphate has not
been identified and acetyl phosphate has not been detected in E. histolytica.
A recent study disputed this hypothesized role for EhACK. This study also argued
against a possible role for EhACD in ATP production via the pyruvate to acetate pathway
in E. histolytica (138). However, the complete abolishment of acetate production in
EhACD silenced cells indicated EhACD is the primary acetate producing pathway in E.
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Figure 1.6: Acetate producing pathways in E. histolytica. EhACK: acetate kinase;
EhACD: acetyl-CoA synthetase (ADP-forming); EhSAT: serine acetyltransferase; EhCS:
cysteine synthase.
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histolytica. Since EhACD converts one mole of acetyl-CoA, ADP, and Pi to one mole of
CoA, ATP and acetate, an elimination of acetate production in EhACD silenced cells are
expected to affect intracellular ATP concentration. Though, Pineda et al. (138) did not
observed a change in ATP level and no glycolytic enzyme activities from cell lysate as
accommodation in EhACD silenced cells. Thus, this presents an inconsistencies with
existing data.
Nutrient acquisition and efficiency of energy metabolism are always proportional
to fitness. Yet, our understanding regarding these topics in E. histolytica is still lacking
and shrouded in mystery. Due to this gap in knowledge, glycolysis has long been
believed to be the main ATP generating pathway even though the majority of infections
reside in the glucose-limited environment of the colon. This presents a need for further
studies into E. histolytica metabolism.
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ACETATE KINASE:
Acetate kinase (ACK), a phosphotransferase, was discovered in 1944 (139) and
first kinetically characterized in 1954 (140). This enzyme catalyzes the reversible transfer
of phosphate from acetyl phosphate to a phosphoryl acceptor (S), yielding acetate and a
phosphorylated product (S-P) (Eq. 14).
Eq. 14: Acetyl phosphate + S acetate + S-P
Previously, ACK’s presence was believed to be limited only to microbes in the
Bacteria and Archaea domains. However, in recent years ACK had also been identified
in several eukaryotic microbes such as algae, some fungi, and Entamoeba histolytica(43).
Phosphoryl transfer is a common enzymatic occurrence within the cell, functioning from
cellular signaling to energy metabolism and storage. Ordinarily, ACK produces ATP or
ADP as an additional product to acetate, thus playing a role in energy conversion.
Currently, two types of ACK have been identified and characterized: ATP-
dependent and pyrophosphate-dependent (PPi) ACK. PPi-dependent ACK is a rare
isoform and at present, has only been identified in Entamoeba histolytica, whereas ATP-
dependent ACK is widespread and found in all three domains of life.
ATP-Acetate Kinase
ACK is of major importance in prokaryote fermentative metabolism, providing
an ATP-yielding pathway during anaerobic conditions. ATP-ACK converts acetyl
phosphate to acetate by utilizing ADP as a phosphoryl acceptor to produce ATP (Eq. 1).
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In 2001, Buss et al.(141) solved the first structure for the ACK from Methanosarcina
thermophila and classified it to be a member of the acetate and sugar kinase-hsp70-actin
(ASKHA) superfamily.
ACK forms a homodimer and is described to resemble a “bird with spreading
wings” (Figure 1.7) (141). The C-terminal domain of ACK composes the body of the bird
and acts as the interface of dimerization between the two monomers. The N-terminal
domain forms the wing portion of the bird. Both domains come together and form the
active site cleft.
Members of the ASKHA superfamily are known to experience domain motion
during catalysis. Gorrell et al. (142) previously used tryptophan fluorescence quenching to
analyze MtACK domain closure upon substrate binding. Their study found domain
motion only occurs upon nucleotide binding. The study also indicated that nucleotide
binding to one monomer of MtACK affects nucleotide binding to the other monomer,
suggesting a half-site mechanism where only one active site is substrate bound at a given
time. The ACK catalytic reaction proceeds through a direct, in-line mechanism, though
this has not always been the accepted truth. From early studies, two mechanisms were
proposed: the direct, in-line and the triple displacement mechanisms of phosphoryl
transfer.
Anthony and Spector (143) discovered E. coli ACK can be phosphorylated with [γ-
32P]-ATP or [32P]-acetyl phosphate. Later, the same group demonstrated E. coli ACK
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Figure 1.7: The structure of Methanosarcina thermophila acetate kinase. The two
monomers are displayed in green and blue, forming a homodimer complex at the C-
terminal interface. Sulfate and ADP are shown in space filling model, illustrating the
active site. Figure obtained and modified from [141] with permission.
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phosphoenzyme formation is dependent on the phosphorylating agent concentration and
is chemically competent, being able to transfer the phosphate group to ADP to produce
ATP or to acetate to produce acetyl phosphate (144). Blattler and Knowles (145) further
noted ACK phosphoryl transfer resulted in an inversion at the phosphorus atom. Based on
these evidence, Spector (146) concluded ACK must proceed through multiple SN2-
displacements to be compatible with both a phosphoenzyme intermediate and an inverted
phosphorus. Spector (146) proposed that ACK catalysis proceeds with two phosphoenzyme
intermediates and three phosphoryl displacements, each causing a phosphate inversion
event to yield a net inversion in the transfer of phosphate (Figure 1.8).
However, the phosphoenzyme transfer rate did not prove to be consistent with
ACK steady state kinetics (140, 144, 147). The triple displacement mechanism was further
challenged when Fox and colleagues(148) reported the E. coli ACK phosphoenzyme can
also reversibly transfer the phosphoryl group to Enzyme I of the phosphotransferase
system. This suggested the true function of the ACK phosphoenzyme may not pertain to
the conversion of acetyl phosphate to acetate.
In 1974, Todhunter and Purich (149) indicated an unspecified glutamate residue
was the site of phosphorylation in E. coli ACK. Singh-Wissman et al. (150) identified five
highly conserved glutamate residues (Glu-32, Glu-97, Glu-334, Glu-384, and Glu-385) in
M. thermophila ACK (MtACK). Site-directed replacement of these residues and
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Figure 1.8: Schematic of the proposed ACK triple displacement mechanism of
phosphoryl transfer. The γ-phosphate of ATP is transferred to a catalytic carboxyl
group and is then transferred to an unknown group (X) prior to transfer to acetate. Figure
obtained and modified from [146] with permission.
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characterization of the variants indicated Glu-384 was essential for catalysis. Glu-385 and
Glu-97, on the other hand, were found to have a role in substrate binding; alteration of
Glu-385 affected both ATP and acetate binding but alteration of Glu-97 appeared to only
affect acetate binding. Despite these studies, the site of glutamate phosphorylation
remained unsettled.
A later study conducted by Miles et al. (151) confirmed the importance of Glu-384
in enzyme activity. Further analysis implicated Glu-384 in magnesium binding, as
evidence by the 30-fold increase in magnesium concentration required for half-maximal
activity for Glu-384-Ala variant. Additionally, Miles et al. noted the importance of Asn-7
and Asp-148 in catalysis (151). Alterations at these two residues resulted in a 260 to 1800
fold reduction in kcat.
The proposed direct in-line mechanism of transfer involves a single phosphate
displacement event. In this mechanism, the substrates bind to ACK in a linear
configuration that facilitates the direct transfer of phosphate from acetyl phosphate to
ADP. This direct in-line transfer of phosphate is consistent with both steady state kinetic
and stereochemistry data, providing initial support for this mechanism of transfer.
Additional studies later offered unambiguous evidence that ACK proceeds
through a direct, in-line mechanism of phosphoryl transfer. Formation of an abortive
complex from using ADP – AlF3 – acetate to simulate the catalytic transition state in
ACK acted as the most substantial evident for supporting this mode of transfer (152).
Employing aluminum fluoride to mimic the planar phosphoryl transition state, Miles et
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al. (152) reported MgCl2, ADP, AlCl3, NaF, and acetate inhibit MtACK activity,
demonstrating that the ACK catalytic transition state requires both ADP and acetate to
form. Gorrell et al. (153) co-crystallized MtACK with acetate, ADP, Al3+ and F-. The
resulting structure showed ADP-AlF3-acetate formed a linear array within the active site
cleft (153). This piece of evidence confirmed a direct in-line transfer mechanism and
effectively ended the debate.
In the same study, Gorrell et al. (153) noted the importance of residues Arg-91 and
Arg-241 in MtACK catalysis. Based on the crystal structure of MtACK, Buss et al. (141)
proposed Arg-91 interacts with the phosphoryl group of acetyl phosphate and Arg-241
interacts with the carboxyl group of acetate. Analysis of MtACK Arg-91 and Arg-241
variants argued against a role for Arg-91 in acetyl phosphate binding (153). A substantial
increased in the Km for acetate in both Arg-91 and Arg-241 variants supported the
proposed role for Arg-241 in acetate binding and suggested Arg-91 may share a similar
role. In all instances, replacing Arg-91 or Arg-241 reduced kcat considerably, establishing
the importance of these two residues in catalysis. These data are in accordance with a
previous investigation to identify essential arginines in ACK by Singh-Wissman et al.
(154)
.
Ingram-Smith et al. (155) identified two essential histidine residues in MtACK
catalysis. Using a diethylpyrocarbonate (DEP) inactivation study, two to three histidine
residues were correlated to have been modified and inactivated MtACK. Sequence
alignment showed His-123, His-180, and His-208 are fully conserved in 56 ACK
sequences. Structural analysis indicated His-123 and His-180 are located within MtACK
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active site. Alanine variants at His-123 or His-180 showed only partial alleviation of
enzyme inactivation by DEP, suggesting both sites are needed for full inactivation by
DEP modification. Of the eight histidines present in MtACK, only the His-180-Ala
variant proved detrimental to enzyme catalysis, reducing kcat by 100 fold. Further
investigation proved His-180 is important in catalysis but was not related to enzyme
phosphorylation.
Based on the MtACK structure, Ingram-Smith et al. (156) later reported Val-93,
Leu-122, Phe-179, and Pro-232 formed the hydrophobic site for acetate binding. The Km
for acetate increased 7 to 26 fold in alanine variants created at each of the four residues,
indicating they do indeed play a role in acetate binding. Phe-179 also proved to be
essential for catalysis, as evidence by a 480 fold decreased in kcat when altered to alanine.
Combined with structural modeling, hydrophobicity was reported to have a role in
determining substrate selectivity, interacting with the methyl group and positioning the
carboxyl group of acetate. Acetyl phosphate binding proved to not rely on hydrophobic
interaction as for acetate but may depend more on the phosphoryl group interaction.
In phosphoryl substrate binding, Bork et al. (157) have identified three signature
ATPase motifs, designated as ADENOSINE, PHOSPHATE1, and PHOSPHATE2, in the
ASKHA superfamily. The PHOSPHATE2 and ADENOSINE motifs are positioned
adjacent to one another on the C-terminal domain within the active site. The
PHOSPHATE1 motif is located on the N-terminal domain across from the
PHOSPHATE2 and ADENOSINE motifs in the active site. Together, these three motifs
form the adenosine pocket and interact with ATP and ADP.
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In 2014, Yoshioka et al. (158) examined four residues in the ADENOSINE motif
and one residue in the PHOSPHATE 2 motif of E. coli ACK to examine their role in
phosphoryl substrate determination. The candidate residues Asn-213, Gly-332, Gly-333,
Ile-334 and Asn-337 were altered to the corresponding residues in EhACK (Thr, Asp,
Gln, Met, and Glu, respectively). These variants displayed a rise in Km for ATP and
substantially decreased thermal stability when ATP was bound when compared to wild-
type. Among 2625 ACK homologs, Yoshioka et al. (158) concluded Asn-337 (Glu-327 in
EhACK) as the most significant out of the five sites in determining phosphoryl substrate
specificity due to its high conservation in ACKs closely related to EhACK. Asp-337-Glu
variant did displayed approximately 45-fold increase in Km for ATP but only showed
minor decreased in catalysis, demonstrating an inconsistency with their conclusion.
Though, their data do support Gly-333 and Ile-334 playing an important role in ATP
selectivity with Gly-333-Gln and Ile-334-Met variants demonstrating over a 7-fold and 9-
fold increase in Km for ATP and a 21-fold and 86-fold in kcat, respectively.
Most recently, Ingram-Smith et al. (159) targeted Asn-211 in the PHOSPHATE2
motif, the highly conserved Gly-331 in the ADENOSINE motif, and Gly-239 to study the
broad NTP utilization of MtACK. These residues were individually altered to alanine or
residues present in the E. histolytica (Thr, Gln, Ser) or Cryptococcus neoformans (Ser,
Gly, Gly) ACKs, respectively. The Gly-331-Gln variant displayed a notable 4.6-fold
increase in the Km for ATP and a 45-fold decrease in kcat, evidence of steric hindrance
impacting ATP binding and catalysis. To a lesser extent, the Gly-331-Ala alteration
reduced catalysis by 8-fold and exhibited a relatively minor increase in Km for ATP.
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Alterations at Asn-211 and Gly-239 diminished enzymatic activity but did not
considerably affect the Km for ATP. The investigations by Yoshioka et al. (158) and
Ingram-Smith et al.(159) demonstrated the vital role of the ADENOSINE and
PHOSPHATE2 motifs in ATP binding to ACK. However, the source of phosphoryl
substrate specificity determination remained unidentified.
PPi – acetate kinase
As compare to the widespread ATP-dependent acetate kinase, E. histolytica
possesses a more uncommon PPi/Pi – dependent ACK. Instead of using ATP/ADP as the
phosphoryl donor/acceptor, the E. histolytica ACK (EhACK) relies solely on PPi/Pi as the
phosphoryl donor/acceptor (Eq. 10) (49, 50). This is the only known ACK that utilizes
pyrophosphate and inorganic phosphate as a phosphoryl donor and acceptor.
EhACK was identified in 1962 and first described in 1975 by Reeves and
colleagues to be PPi/Pi – dependent (50, 160). However, due to the molecular and
biochemical limitations of the time, EhACK has only recently been thoroughly
characterized biochemically and kinetically. EhACK activity was confirmed to
exclusively depend on pyrophosphate and inorganic phosphate (49). In addition, EhACK
was described to also follow a direct, in-line mechanism of phosphoryl transfer and
preferentially proceed in the acetate/PPi forming direction with a kcat several hundred –
fold higher than that for the acetyl phosphate/Pi producing direction.
In 2013, Thaker et al. successfully solved the EhACK structure (Figure 1.9) (161).
The structure was compared to the well-studied, ATP–dependent MtACK. Overall, the
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structure and active site of EhACK highly resembles MtACK, exhibiting a homodimeric
form and resembling like a bird with spread wings (161). However, upon closer inspection,
Gly–331 and Ile–332 within the ATP binding pocket of MtACK were noted to be
replaced by glutamine and methionine at the corresponding location in EhACK (161).
These differences were suggested to play a role in EhACK PPi/Pi specificity by sterically
reducing ATP binding. Furthermore, a salt bridge between aspartate–272 and arginine–
274 in EhACK placed the arginine in a position that could further obstruct ATP binding
(Figure 1.10). Surface representation of EhACK clearly illustrates an absent of the
adenosine binding pocket due to this obstruction. However, this has not yet been
experimentally examined and confirmed. Thus, the source of EhACK phosphoryl
substrate selectivity remained to be confirmed.
In this thesis, I investigated the source of EhACK phosphoryl substrate specificity
using the well-studied MtACK as a model for comparison. Additionally, acetate
metabolism in E. histolytica was also explored. Specifically, I studied the physiological
effects of silencing two acetate producing enzymes in this human parasite, acetate kinase
and ADP-forming acetyl-CoA synthetase, to identify their roles in E. histolytica growth
and survival. My results showed that ACD plays a role in utilization of several growth
substrates in addition to glucose, whereas ACK plays a novel role unrelated to its
previously proposed role in providing PPi for glycolysis.
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Figure 1.9: Crystal structure of E. histolytica ACK. The N-terminal domain is colored
in green and the C-terminal domain is in cyan. The putative active site is marked by oval
and triangle. Figure obtained and modified from [161] with permission.
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Figure 1.10: Active site architecture of MtACK and EhACK. A: Surface
representation of the MtACK active site. B: Close up view of the ATP/ADP binding cleft
of MtACK. C: Surface representation of the EhACK active site. D: Close up view of the
PPi/Pi binding site of EhACK. Residues proposed to obstruct ATP/ADP binding in
EhACK are circled along with corresponding residues found in MtACK. Figure obtained
and modified from [161] with permission.
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CHAPTER II
INVESTIGATION OF PYROPHOSPHATE VERSUS ATP SUBSTRATE 
SELECTION IN THE ENTAMOEBA HISTOLYTICA ACETATE KINASE 
Thanh Dang and Cheryl Ingram-Smith
ABSTRACT:
Acetate kinase (ACK; E.C. 2.7.2.1), which catalyzes the interconversion of acetate
and acetyl phosphate, is nearly ubiquitous in bacteria but is present only in one genus of
archaea and certain eukaryotic microbes. All ACKs utilize ATP/ADP as the phosphoryl
donor/acceptor in the respective directions of the reaction (acetate + ATP  acetyl
phosphate + ADP), with the exception of the Entamoeba histolytica ACK (EhACK) which
uses pyrophosphate (PPi)/inorganic phosphate (Pi) (acetyl phosphate + Pi acetate + PPi.
Structural analysis and modeling of EhACK indicated steric hindrance by active site
residues constricts entry to the adenosine pocket as compared to ATP-utilizing
Methanosarcina thermophila ACK (MtACK). Reciprocal alterations were made to enlarge
the adenosine pocket of EhACK and reduce that of MtACK. The EhACK variants showed
a step-wise increase in ADP and ATP binding but were still unable to use these as
substrates, and enzymatic activity with Pi/PPi was negatively impacted. Consistent with
this, ATP utilization by MtACK variants was negatively affected but the alterations were
not sufficient to convert this enzyme to Pi/PPi utilization. Our results suggest that
controlling access to the adenosine pocket can contribute to substrate specificity but is not
the sole determinant.
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INTRODUCTION:
Acetate kinase (ACK; E.C. 2.7.2.1) catalyzes the reversible transfer of phosphate
from acetyl phosphate to a phosphoryl acceptor (S), yielding acetate and a phosphorylated
product (S–P) [Eq.1]. ACK, nearly ubiquitous in bacteria, has been identified in just a
single genus of archaea, Methanosarcina. In recent years, ACK has also been identified in
certain eukaryotic microbes including the green algae Chlamydomonas, euascomycete and
basidiomycete fungi, and certain protists, namely Entamoeba histolytica (1).
[Eq. 1] Acetyl phosphate + S acetate + S-P
This enzyme was discovered in 1944 (2) and the first kinetic characterization was
reported in 1954 (3). In 2001, Buss et al. solved the structure for the Methanosarcina
thermophila ACK (MtACK), and subsequent studies with this archaeal enzyme determined
that ACK proceeds through a direct in-line mechanism of phosphoryl transfer (4-6). Acyl
substrate selection in ACK has been studied in the Methanosarcina enzyme. Four key
residues, Val93, Leu122, Phe179, and Pro232, have been shown to form a hydrophobic pocket
for acetate binding (7) which were implicated in acyl substrate selection in this enzyme. In
particular, Val93 appears to play an important role in limiting substrate length.
Ordinarily, ACK utilizes ATP/ADP as phosphoryl donor/acceptor; however, the E.
histolytica enzyme is unusual in that it is PPi–dependent. Instead of using ATP/ADP as the
phosphoryl donor/acceptor [Eq. 2], E. histolytica ACK (EhACK) can only use
pyrophosphate (PPi)/inorganic phosphate (Pi) as the phosphoryl donor/acceptor [Eq.3] (8-
10)
.
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[Eq. 2] Acetyl phosphate + ADP  acetate + ATP
[Eq. 3] Acetyl phosphate + Pi acetate + PPi
Whereas most ATP-dependent ACKs function in both directions of the reaction,
the E. histolytica enzyme strongly prefers the acetate-forming direction (8-10). Double
reciprocal plots of substrate concentration versus enzyme activity indicated EhACK
follows a ternary–complex mechanism (8-10), supporting a direct in-line mechanism of
phosphoryl transfer as seen for MtACK (4-6). Currently, EhACK is the only known ACK to
utilize pyrophosphate or inorganic phosphate as a phosphoryl donor or acceptor instead of
ATP/ADP.
ACK belongs to the ASKHA (acetate, sugar kinase, heat shock and actin) enzyme
superfamily. In 1992, Bork et al. identified PHOSPHATE1, PHOSPHATE2 and
ADENOSINE as three signature ATPase motifs shared by members of this superfamily
(11)
. These three conserved motifs form part of the adenosine binding pocket and are directly
involved in ATP binding. Thaker et al. solved the EhACK structure and noted two amino
acids substitutions in the ADENOSINE motif versus MtACK that may sterically hinder
ATP binding (12).
Here, we investigated the role of residues in the ADENOSINE and PHOSPHATE2
motifs in phosphoryl substrate selection and utilization in ACK. Our results indicated that
the adenosine pocket and the ADENOSINE motif play a critical role in ATP binding.
However, ATP binding alone did not lead to utilization. Thus, although EhACK shares
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strong similarities with ATP-dependent ACKs, subtle differences have dramatically shaped
its identity and function.
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MATERIALS AND METHODS:
Materials
Chemicals were purchased from Sigma-Aldrich, VWR International, Gold
Biotechnology, Fisher Scientific, and Life Technologies. Oligonucleotide primers were
purchased from Integrated DNA Technologies.
Site-directed mutagenesis
Site-directed mutagenesis of the E. histolytica ack (ehack) and M. thermophila
ack (mtack) genes was performed according to manufacturer’s instructions with the
QuikChange II kit (Agilent Technologies, CA, USA). The altered sequences were
confirmed by sequencing at the Clemson University Genomics Institute. Mutagenesis
primers used are shown in Table 2.1.
Recombinant protein production
EhACK and its variants were produced in Escherichia coli strain YBS121 ∆ack
∆pta carrying the pREP4 plasmid containing the lacI gene and purified as described in
Fowler et al. (9). MtACK and its variants were produced in E. coli Rosetta2 (DE3) pLysS
and purified as described in Fowler et al. (9). Purified enzymes were dialyzed overnight in
25 mM Tris–HCl, 150 mM NaCl, and 10% glycerol (pH 7.4), aliquoted, and stored at -
80ºC. Recombinant enzymes were examined by SDS–PAGE and estimated to be greater
than 95% pure. Protein concentration was measured by absorbance at 280nm using Take3
micro–volume plate (Biotek, VT, USA).
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EhACK primers
Q323G-M324I F 5’GATCTTTTAGTATTTACTGATGGCATCGGATTAGAAGTTTGGCAAGTACG
Q323G-M324I R 5’CGTACTTGCCAAACTTCTAATCCGATGCCATCAGTAAATACTAAAAGATC
Q323A-M324A F 5’GATCTTTTAGTATTTACTGATGCCGCGGGATTAGAAGTTTGGCAAGTACG
Q323A-M324A R 5’CGTACTTGCCAAACTTCTAATCCCGCGGCATCAGTAAATACTAAAAGATC
D272A-R274A F 5’GGTGTTAGTGAATTATCTAGTGCTATGGCAGATATTTTACATGAAATAG
D272A-R274A R 5'CTATTTCATGTAAAATATCTGCCATAGCACTAGATAATTCACTAACACC
G203 Deletion F 5’GCTTGTCATCTTGGAACAGGTTCTAGTTGTTGTGGCATTGTTAATGG
G203 Deletion R 5’CCATTAACAATGCCACAACAACTAGAACCTGTTCCAAGATGACAAGC
MtACK primers
G331Q-I332M F 5’ GCAGTGGTCTTTACTGCACAGATGGGAGAAAACAGCGCAAGC
G331Q-I332M R 5’ GCTTGCGCTGTTTTCTCCCATCTGTGCAGTAAAGACCACTGC
Table 2.1: Primers used for mutagenesis.
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Determination of kinetic parameters
Kinetic parameters for the EhACK enzymes were determined using the
colorimetric hydroxamate assay for the acetyl phosphate-forming direction (2, 3, 17) and the
reverse modified hydroxamate assay (9, 22) for the acetate-forming direction as previously
described (9). In the acetyl phosphate-forming direction, activities for EhACK and its
variants were assayed in a mixture containing 100mM morpholinoethanesulfonic acid
(pH 5.5), 5 mM MgCl2, and 600 mM hydroxylamine hydrochloride (pH 7.5) with varying
concentrations of acetate and sodium pyrophosphate. Reactions were performed at 45°C.
For the acetate-forming direction, kinetic parameters were determined in a mixture of 100
mM Tris–HCl (pH 7.0) and 10 mM MgCl2 with varying concentrations of sodium
phosphate and acetyl phosphate. Enzymatic reactions were performed at 37°C.
The acetyl phosphate produced (acetyl phosphate-forming direction) or remaining
(acetate-forming direction) was reacted with hydroxylamine to produced acetyl
hydroxamate, which was then was converted to a ferric hydroxamate complex by reaction
with an acidic ferric chloride solution, making the solution change from a yellow to
brownish red color that can detected spectrophotometrically at 540 nm. Acetyl phosphate
formation or depletion was determined by measuring the absorbance at 540 nm with an
Epoch microplate spectrophotometer (Biotek) and comparison to an acetyl phosphate
standard curve. Kinetic data were fit to the Michaelis-Menten equation by nonlinear
regression using KaleidaGraph (Synergy Software) for determination of apparent kinetic
parameters.
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Similarly, kinetic parameters for MtACK and its variants were determined using
the hydroxamate assay (2, 3, 17) and the reverse modified hydroxamate assay (9, 22) as
previously described. In the acetate-forming direction, enzyme activities were determined
in 100 mM Tris (pH 7.5) with varying concentrations of MgADP and acetyl phosphate.
For the acetyl phosphate-forming direction, kinetic parameters were determined in 100
mM Tris (pH 7.5) and 600 mM hydroxylamine (pH 7.5) with varying concentrations of
acetate and MgATP. Enzymatic reactions were performed at 37°C.
Acetyl phosphate formation and depletion were determined by measuring the
absorbance at 540 nm with an Epoch microplate spectrophotometer (Biotek) and
comparison to an acetyl phosphate standard curve. Kinetic data were fit to the Michaelis-
Menten equation by nonlinear regression using KaleidaGraph (Synergy Software) for
determination of apparent kinetic parameters.
Determination of inhibition parameters
Inhibition of EhACK by ATP and ADP and of MtACK by PPi was determined
using the hydroxamate and reverse modified hydroxamate assays as described above. All
inhibition assays were performed using substrates at their Km concentrations, with the
exception of acetyl phosphate which was used at a concentration of 2 mM for all
reactions in the acetate–forming direction. The half maximal inhibitory concentrations
(IC50 values) were determined using PRISM 5 (Graphpad Software). ATP’s mode of
inhibition of wild-type EhACK was determined by measuring enzymatic activity in the
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acetate forming direction in a four by seven matrix of varied ATP and Pi concentrations,
with other substrate concentrations kept constant.
ACK sequence alignment, ConSurf analysis, and structural modeling
ACK sequences were obtained from NCBI. Accession numbers are as follows: E.
histolytica, PDB ID 4H0O; Methanosarcina thermophila, PDB ID 1TUY; Cryptococcus
neoformans, PDB ID 4H0P; Salmonella typhimurium, PDB ID 3SLC; Thermotoga
maritima, PDB ID 2IIR; Mycobacterium smegmatis, PDB ID 4IJN; Mycobacterium
avium, PDB ID 3P4I; Mycobacterium paratuberculosis, PDB ID 3R9P; Mycobacterium
marinum PDB ID 4DQ8. Sequences alignments were performed using Clustal Omega (23-
25)
. ACK structures were downloaded from Protein Data Bank (PDB): 4H0O (Entamoeba
histolytica), 1TUY (M. thermophila), 4H0P (C. neoformans), and 3SLC (S.
typhimurium). Structure superposition and modeling were performed using Accelrys
Discovery Studio 3.5 (Biovia). ConSurf analysis (26-28) (http://consurf.tau.ac.il) was used
to examine evolutionary conservation of ACK sequence and identify amino acids likely
to play important structural and functional roles.
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RESULTS:
Structures have been solved for six bacterial (four of which are from
Mycobacterium), one archaeal, and two eukaryotic ACKs (4, 12-14). Although the global
structures are similar, the percent identity and similarity between these ACK sequences
showed that the eukaryotic ACKs are less related to the bacterial and archaeal enzymes
(Table 2.2). Previous phylogenetic analysis revealed that fungal ACKs belong to a
distinct clade but the E. histolytica and other eukaryotic sequences group with the
bacterial and archaeal ACKs (1). Thus, the unique Pi/PPi-dependence of EhACK must be
due to localized differences in the active site.
Structural differences between the adenosine binding pocket of PPi - and ATP-ACKs
In addition to the PHOSPHATE1, PHOSPHATE2, and ADENOSINE sequence
motifs, Ingram-Smith et al. (15) defined two other regions designated as LOOP3 and LOOP4
that also influence ATP binding in ACK. Inspection of the active site in the MtACK
structure showed that these regions surround the ATP binding site, with ADENOSINE
forming a hydrophobic pocket for the adenosine moiety of ADP/ATP (4, 7, 10, 12, 15). ConSurf
analysis, which estimates the evolutionary conservation at each position based on
phylogenetic and structural analysis, indicated that the central positions in the
ADENOSINE motif have the highest conservation level (Figure 2.1). Positions 322-327 of
EhACK are of particular note as this region of the ADENOSINE motif is strongly
conserved in other ACKs but not EhACK.
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E.hist M.therm C.neo S.typh T.mari M.smeg M.avium M.para M.mari
E.hist 35/53 29/44 34/50 38/57 34/50 31/46 32/46 30/47
M.therm 35/53 31/49 44/62 57/76 41/59 41/59 41/58 41/58
C.neo 29/44 31/49 33/49 32/48 31/47 33/47 33/47 33/48
S.typh 34/50 44/62 33/49 46/67 44/58 40/55 41/55 41/55
T.mari 38/57 57/76 32/48 46/67 47/61 45/60 45/59 43/59
M.smeg 34/50 41/59 31/47 44/58 47/61 67/77 67/77 67/78
M.avium 31/46 41/59 33/47 40/55 45/60 67/77 98/98 73/84
M.para 32/46 41/58 33/47 41/55 45/59 67/77 98/98 73/84
M.mari 30/47 41/58 33/48 41/55 43/59 67/78 73/84 73/84
Table 2.2: Percent identity and similarity between ACKs.
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Figure 2.1: Partial alignment of ACK amino acid sequences. Sequences of ACKs for
which the structure have been solved were aligned and ConSurf analysis was performed to
examine sequence conservation. The PHOSPHATE2 and ADENOSINE motifs are shown.
The full alignment is provided in the Figure 2.2. Abbreviations and PDB accession
numbers: E.hist, E. histolytica, PDB ID 4H0O; M.therm, Methanosarcina thermophila,
PDB ID 1TUY; C.neo, Cryptococcus neoformans, PDB ID 4H0P; S.typhi, Salmonella
typhimurium, PDB ID 3SLC; T.mari, Thermotoga maritima, PDB ID 2IIR; M.smeg,
Mycobacterium smegmatis, PDB ID 4IJN; M.avium, Mycobacterium avium, PDB ID 3P4I;
M.para, Mycobacterium paratuberculosis, PDB ID 3R9P; M.mari, Mycobacterium
marinum PDB ID 4DQ8.
PHOSPHATE2
E.hist 193 KIIACHLGTGGSSCCGIV  210
M.therm 203 KIITCHLGNG-SSITAVE  219
C.neo 215 NVVVAHLGSG-SSSCCIK  231
S.typh 205 NIITCHLGNG-GSVSAIR  221
T.mari 202 KIITCHIGNG-ASVAAVK  218
M.smeg 184 NQIVLHLGNG-ASASAVA  200
M.avium 192 KQIVLHLGNG-CSASAIA  208
M.para 192 KQIVLHLGNG-CSASAIA  208
M.mari 192 NQIVLHLGNG-ASASAVA  208
: :. *:*.*  *   :
CONSURF 857879899696923951
ADENOSINE
E.hist 317  LLVFTDQMGLEVWQVRKA  334
M.therm 325  AVVFTAGIGENSASIRKR  342
C.neo 355  GLVFSGGIGEKGAELRRD  372
S.typh 327  AVVFTGGIGENAAMVREL  344
T.mari 325  AIVFTAGVGENSPITRED  342
M.smeg 305  VISFTAGVGENVPPVRRD  322
M.avium 313  VISFTAGIGENDAAVRRD  330
M.para 313  VISFTAGIGENDAAVRRD  330
M.mari 313  VVSFTAGIGEHDAAVRRD  330
: *:  :* .    *.
CONSURF 456998969996111911
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____PHOSPHATE1_____
T.mari -------MRVLVINSGSSSIKYQLIEMEGEKVLC-------KGIAERIGIEGSRLVHRVG 46
M.therm -------MKVLVINAGSSSLKYQLIDMTNESALA-------VGLCERIGIDNSIITQKKF 46
M.avium MDGSDGARRVLVINSGSSSLKFQLVDPESGVAAS-------TGIVERIGEESS------- 46
M.para MDGSDGARRVLVINSGSSSLKFQLVDPEFGVAAS-------TGIVERIGEESS------- 46
M.smeg ------MVTVLVVNSGSSSLKYAVVRPASGEFLA-------DGIIEEIG--SG------- 38
S.typh ----MSSKLVLVLNCGSSSLKFAIIDAVNGDEYL-------SGLAECFHLPEARIKWKMD 49
E.hist ------MSNVLIFNVGSSSLTYKVFCSDNIVCSG-------KSNRVNVTGTEKPFIEHHL 47
C.neo --MPDKAEYLLAINCGSSSIKGKLFAIPSFELLANLAVTNISSSDERVKIKTTWEEGKGK 58
:* .* ****:.  :.                 .  .
T.mari DEKHVIER-ELPDHEEALKLILNTLVDEKLGVIKDLKEIDAVGHRVVHGGERFKESVLVD 105
M.therm DGKKLEKLTDLPTHKDALEEVVKALTDDEFGVIKDMGEINAVGHRVVHGGEKFTTSALYD 106
M.avium ---------PVPDHDAALRRAFDMLAGD--GVDLNTAGLVAVGHRVVHGGNTFYRPTVLD 95
M.para ---------PVPDHDAALRRAFDMLAGD--GVDLNTAGLVAVGHRVVHGGNTFYRPTVLD 95
M.smeg ---------AVPDHDAALRAAFDELAAA--GLHLEDLDLKAVGHRMVHGGKTFYKPSVVD 87
S.typh GSKQEAALGAGAAHSEALNFIVNTILAQ---KPELSAQLTAIGHRIVHGGEKYTSSVVID 106
E.hist NGQIIKIETPILNHPQAAKLIIQFLKEN-------HISIAFVGHRFVHGGSYFKKSAVID 100
C.neo DSEEEADYGDKIRYASLVPILLDHLTNS---THVKKEEIKYVCHRVVHGGMHDKGIRVVK 115
:       .. :             :  : **.****  : .
T.mari --EEVLKAIEEVSPLAPLHNPANLMGIKAAMKLLPGVP--NVAVFDTAFHQTIPQKAYLY 161
M.therm --EGVEKAIKDCFELAPLHNPPNMMGISACAEIMPGTP--MVIVFDTAFHQTMPPYAYMY 162
M.avium --DAVIARLHELSELAPLHNPPALLGIEVARRLLPGIA--HVAVFDTGFFHDLPPAAATY 151
M.para --DAVIARLHELSELAPLHNPPALQGIEVARRLLPDIA--HVAVFDTGFFHDLPPAAATY 151
M.smeg --DELIAKARELSPLAPLHNPPAIKGIEVARKLLPDLP--HIAVFDTAFFHDLPAPASTY 143
S.typh --ESVIQGIKDSASFAPLHNPAHLIGIAEALKSFPQLKDKNVAVFDTAFHQTMPEESYLY 164
E.hist --EVVLKELKECLPLAPIHNPSSFGVIEISMKELPTTR--QYVAIDTAFHSTISQAERTY 156
C.neo GHEEGLMEMDKLSEFAPLHNHRAVLAVKSCIDALPHHT--SLLLFDTIFHRTIAPEVYTY 173
:       .   :**:**   .  :  .   :*         :** *.  :.     *
____PHOSPHATE2____
T.mari AIP-YEYYEKYKIRRYGFHGTSHRYVSKRAAEILGKKLEELKIITCHIGNG-ASVAAVKY 219
M.therm ALP-YDLYEKHGVRKYGFHGTSHKYVAERAALMLGKPAEETKIITCHLGNG-SSITAVEG 220
M.avium AID-RELADRWQIRRYGFHGTSHRYVSEQAAAFLDRPLRGLKQIVLHLGNG-CSASAIAG 209
M.para AID-RELADRWQIRRYGFHGTSHRYVSEQAAAFLDRPLRGLKQIVLHLGNG-CSASAIAG 209
M.smeg AID-RELAETWHIKRYGFHGTSHEYVSQQAAIFLDRPLESLNQIVLHLGNG-ASASAVAG 201
S.typh ALP-YSLYKEHGVRRYGAHGTSHFYVTQEAAKMLNKPVEELNIITCHLGNG-GSVSAIRN 222
E.hist AIP-QPYQSQY--LKFGFHGLSYEYVINSLKNVID--VSHSKIIACHLGTGGSSCCGIVN 211
C.neo ALPPPDTELTMPLRKYGFHGLSYASIVQSLAEHLKKPSDQINVVVAHLGSG-SSSCCIKN 232
*:            ::* ** *:  : :     :       : :. *:*.*  *   :
________LOOP3_________
T.mari GKCVDTSMGFTPLEGLVMGTRSGDLDPAIPFFIMEKEG-------ISPQEMYDILNKKSG 272
M.therm GKSVETSMGFTPLEGLAMGTRCGSIDPAIVPFLMEKEG-------LTTREIDTLMNKKSG 273
M.avium TRPLDTSMGLTPLEGLVMGTRSGDIDPSVVSYLCHTAG-------MGVDDVESMLNHRSG 262
M.para TRPLDTSMGLTPLEGLVMGTRSGDIDPSIVSYLCHTAG-------MGVDDVESMLNHRSG 262
M.smeg GKAVDTSMGLTPMEGLVMGTRSGDIDPGVIMYLWRTAG-------MSVDDIESMLNRRSG 254
S.typh GKCVDTSMGLTPLEGLVMGTRSGDIDPAIIFHLHDTLG-------MSVDQINKMLTKESG 275
E.hist GKSFDTSMGNSTLAGLVMSTRCGDIDPTIPIDMIQQVG-------IEK--VVDILNKKSG 262
C.neo GKSIDTSMGLTPLEGLLGGTRSGTIDPTAIFHHTEDAASDANVGDFTVSKAEIILNKNSG 292
: .:**** :.: **  .**.* :**          .       :       ::.:.**
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Figure 2.2: ACK sequence alignment. The full ACK sequence alignment from which
Figure 2.1 was derived is shown.
___LOOP4____
T.mari VYGLSKGFSSDMRDIEEAALKG------DEWCKLVLEIYDYRIAKYIGAYAAAMN----- 321
M.therm VLGVS-GLSNDFRDLDEAASKG------NRKAELALEIFAYKVKKFIGEYSAVLN----- 321
M.avium VVGLS--GVRDFRRLRELIESG------DGAAQLAYSVFTHRLRKYIGAYLAVLG----- 309
M.para VVGLS--GVRDFRRLRELIESG------DGAAQLAYSVFTHRLRKYIGAYLAVLG----- 309
M.smeg VLGLG--GASDFRKLRELIESG------DEHAKLAYDVYIHRLRKYIGAYMAVLG----- 301
S.typh LLGLT-EVTSDCRYVEDNYAT-------KEDAKRAMDVYCHRLAKYIGSYTALMDG---- 323
E.hist LLGVS-ELSSDMRDILHEIETRGP---KAKTCQLAFDVYIKQLAKTIGGLMVEIG----- 313
C.neo FKALA--GTTNFGHIIQNLDPSKCSEEDHEKAKLTYAVFLDRLLNFVAQYLFKLLSEVPI 350
. .:      :   : .              .: .  ::  :: : :.     :
_____ADENOSINE____
T.mari -GVDAIVFTAGVGENSPITREDVCSYLEFLGVKLDKQKNEETIRGKEGIISTPDSRVKVL 380
M.therm -GADAVVFTAGIGENSASIRKRILTGLDGIGIKIDDEKNK--IRGQEIDISTPDAKVRVF 378
M.avium -HTDVISFTAGIGENDAAVRRDAVSGMEELGIVLDERRNLPGAKGAR-QISADDSPITVL 367
M.para -HTDVISFTAGIGENDAAVRRDAVSGMEELGIVLDERRNLAGGKGAR-QISADDSPITVL 367
M.smeg -RTDVISFTAGVGENVPPVRRDALAGLGGLGIEIDDALNSAKSDEPR-LISTPDSRVTVL 359
S.typh -RLDAVVFTGGIGENAAMVRELSLGKLGVLGFEVDHERNLAARFGKSGFINKEGTRP-AV 381
E.hist -GLDLLVFTDQMGLEVWQVRKAICDKMKFLGIELDDSLNEKSMGKKIEFLTMPSSKVQVC 372
C.neo ESIDGLVFSGGIGEKGAELRRDVLKKLAWLGAEVDEEANNSNSGGAVKCITKEGSKLKGW 410
* : *:  :* :    *.     :  :*  :*.  *          :.  .:
T.mari VVPTNEELMIARDTKEIVEKIGR------- 403
M.therm VIPTNEELAIARETKEIVETEVKLRSSIPV 408
M.avium VVPTNEELAIARDCVRVLGG---------- 387
M.para VVPTNEELAIARDCVRVLGG---------- 387
M.smeg VVPTNEELAIARACVGVV------------ 377
S.typh VIPTNEELVIAQDASRLTA----------- 400
E.hist VAPNDEELVILQKGKELFQF---------- 392
C.neo VVETDEEGWMARMAKEEFGF---------- 430
*  .:**  : :
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ADP/ATP-utilizing ACKs have a highly conserved Gly residue and an adjacent
Ile/Val within the ADENOSINE motif (positions 331 and 332 in MtACK). Inspection of
the MtACK structure revealed a large opening to the adenosine binding pocket (Figure
2.3A) that is also evident in the structures of other ATP-ACKs. Occlusion of the adenosine
pocket is evident in the surface representation of EhACK (Figure 2.3B). Thaker et al. (12)
postulated that Gln323Met324 within the ADENOSINE motif of EhACK may sterically
prevent ADP/ATP binding.
Role of the ADENOSINE motif in ATP/ADP versus PPi/Pi utilization.
To investigate the role of the ADENOSINE motif in determining substrate
selection, EhACK variants were created that simulate the open adenosine pocket observed
in ATP-dependent ACKs. Gln323 and Met324 were altered to Gly and Ile, respectively, to
mimic the residues found at equivalent positions in MtACK. These positions were also
both altered to Ala to minimize side chain intrusions into the opening of the adenosine
pocket. The reverse alterations were made in MtACK, converting Gly331–Ile332 to Gln–
Met, respectively, to determine the effect of closing the entry to the adenosine pocket. The
EhACK and MtACK variants were purified (Figure 2.4) and kinetic parameters were
determined in both directions of the reaction (Table 2.3).
The Q323G–M324I and Q323A–M324A EhACK variants displayed similar Km values
for acetyl phosphate and slightly decreased Km values for phosphate as the unaltered
enzyme but the kcat values were decreased 8.3-fold for the Q323G–M324I variant and 19-fold
for Q323A–M324A variant, resulting in ~7 and 11-fold reduced catalytic efficiency,
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Figure 2.3: The ACK adenosine binding pocket. (A) Surface representation of MtACK
with bound ADP. (B) Surface representation of EhACK. The constricted opening to the
adenosine pocket is circled. The position of bound ADP in MtACK was superimposed
into the EhACK structure. (C) Superimposition of the adenosine pocket from MtACK
(yellow) and EhACK (cyan) showing the positions of targeted residues. (D)
Superimposed PHOSPHATE2 motifs from MtACK (yellow) and EhACK (cyan),
showing the position of the additional Gly in the EhACK PHOSPHATE2 motif.
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Figure 2.4 SDS-PAGE analysis of purified enzymes. Black vertical lines represent
separate gels.
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Enzyme Substrate Km (mM) kcat (sec-1)
EhACK Acetate-forming direction
Wild-type AcP 0.57 ± 0.03 266 ± 12
Q323G-M324I 0.47 ± 0.04 32 ± 1.0
Q323A-M324A 0.34 ± 0.07 14 ± 1.2
G203deletion-Q323G-M324I No detectable activity
D272A-R274A-Q323G-M324I 0.66 ± 0.11 0.052 ± 0.005
Wild-type Pi 14 ± 1.2 196 ± 5
Q323G-M324I 7.3 ± 0.5 28 ± 1.2
Q323A-M324A 8.2 ± 1.1 20 ± 0.8
G203deletion-Q323G-M324I No detectable activity
D272A-R274A-Q323G-M324I 18 ± 1.2 0.076 ± 0.004
Acetyl phosphate-forming direction
Wild-type Acetate 166 ± 7 1.4 ± 0.05
Q323G-M324I 372 ± 40 0.51 ± 0.02
Q323A-M324A 566 ± 44 0.51 ± 0.03
G203deletion-Q323G-M324I No detectable activity
D272A-R274A-Q323G-M324I No detectable activity
Wild-type PPi 2.1 ± 0.33 0.90 ± 0.03
Q323G-M324I 2.0 ± 0.37 0.45 ± 0.03
Q323A-M324A 2.3 ± 0.41 0.36 ± 0.01
G203deletion-Q323G-M324I No detectable activity
D272A-R274A-Q323G-M324I No detectable activity
MtACK Acetate-forming direction
Wild-type AcP 1.2 ± 0.09 1550 ± 54
G331Q-I332M 1.7 ± 0.14 12 ± 0.7
Wild-type ADP 1.8 ± 0.13 1915 ± 15
G331Q-I332M 5.7 ± 0.56 12 ± 0.5
Acetyl phosphate-forming direction
Wild-type Acetate 20 ± 0.3 789 ± 16
G331Q-I332M 302 ± 11 17 ± 4.2
Wild-type ATP 1.7 ± 0.03 711 ± 23
G331Q-I332M 9.4 ± 0.27 14 ± 0.2
Table 2.3: Apparent kinetic parameters for wild-type and variant EhACKs and
MtACKs.
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respectively. In the direction of acetyl phosphate formation, these variants displayed
slightly increased Km for acetate but no increase in Km for PPi and only mild decrease in
kcat. No activity was observed with either variant using ATP or ADP as substrate in the
respective direction of the reaction.
The G331Q–I332M alteration in MtACK resulted in substantial reductions in kcat
(Table 2.3). In the acetate-forming direction, catalysis was reduced over 100-fold, and in
the acetyl phosphate-forming direction, kcat was reduced ~50-fold. This alteration resulted
in ~5-fold increase in Km for ADP and ATP, and a 15-fold increase in Km for acetate but
no substantial change in the Km for acetyl phosphate. As with wild-type MtACK, no
activity was observed with Pi or PPi as substrate in the respective directions of the
reaction for the MtACK variant.
Additional structural elements may contribute to occlusion of the ATP/ADP binding
pocket
A salt bridge between Arg274 and Asp272 on LOOP4 of EhACK may cause further
constriction of the adenosine pocket by positioning the Arg side chain toward the pocket
(12)
. These two residues are conserved in MtACK but the side chain of Arg is positioned
away from the adenosine pocket. These residues are not conserved among all ACKs
though and LOOP4 does not impinge upon the adenosine pocket. The PHOSPHATE2
motif, which interacts with the β phosphate of ATP and was suggested to have a role in
substrate positioning (4, 11, 15), is longer in EhACK and protrudes farther into the active site
than in the ATP-dependent enzymes (Figure 2.3C). Sequence alignment and structural
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superposition of the PHOSPHATE2 motif illustrate that this difference arises from
addition of a single residue, Gly203 (Figures 2.1 and 2.3D).
To examine whether this salt bridge and the extended PHOSPHATE2 motif
influence substrate selection, EhACK Q323G–M324I variants in which the salt bridge has
been eliminated (D272A–R274A–Q323G–M324I) or in which the PHOSPHATE2 motif has
been shortened (G203– Q323G–M324I) were analyzed. The D272A–R274A–Q323G–M324I
replacement decreased kcat in the acetate-forming direction by ~2,500–5,000 fold but had
little effect on Km for either substrate (Table 2.3). This variant had no detectable activity in
the acetyl phosphate-forming direction (Table 2.3). The G203– Q323G–M324I variant was
inactive in either direction of the reaction, and thus the effect of the Gly203 deletion
compounded onto the D272A–R274A–Q323G–M324I alteration was not examined. No
enzymatic activity was observed with either of these variants using ATP or ADP as the
substrate in place of PPi or Pi.
Inhibition of EhACK and MtACK by alternative phosphoryl donors and acceptors.
Since wild-type EhACK and MtACK cannot utilize ATP/ADP or PPi/Pi,
respectively, as alternative phosphoryl donor/acceptor, inhibition assays were performed
to determine whether these compounds can bind and inhibit activity even if they cannot be
used productively as substrate. EhACK activity was measured in the favored acetate-
forming direction in the presence or absence of 10 mM AMP, ADP, or ATP (Figure 2.5A).
Although AMP had no effect, both ADP and ATP were found to inhibit EhACK activity
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Figure 2.5: Inhibition of EhACK and MtACK by alternative phosphoryl donors and
acceptors. (A) Inhibition of wild-type EhACK in the presence of 10 mM AMP, ADP, or
ATP in the acetate-forming direction of the reaction. (B) Inhibition of wild-type MtACK
in the presence of 20 mM Pi or PPi in the acetate-forming direction. (C) Inhibition of
wild-type MtACK in the presence of 20 mM Pi or PPi in the acetyl phosphate-forming
direction. Significant difference between inhibitions compared to wild-type enzyme
activity is tested using an unpaired Welch t-test with R. * = p-value < 0.001, ** = p-value
< 0.00003, *** = p-value < 0.000008. Activities are the mean ± SD of three replicates.
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but to differing extents. The presence of ATP resulted in nearly 80% inhibition versus
~30% inhibition by ADP. The presence of Pi or PPi with AMP was not sufficient to mimic
the effect of inhibition by ADP or ATP, respectively (data not shown). For MtACK, Pi had
no effect on enzymatic activity. PPi inhibited the enzyme in both directions of the reaction
to differing extents, producing ~70% inhibition in the acetate-forming direction and ~90%
inhibition in the acetyl phosphate-forming direction (Figures 2.5B and 2.5C).
The mode of inhibition of EhACK by ATP was determined by kinetic analysis
using a matrix of reactions in which the ATP concentration was varied versus Pi
concentration with the acetate concentration held constant. ATP was found to be a
competitive inhibitor of EhACK, as demonstrated by the results in Figure 2.6. Further
examination of ATP inhibition of the EhACK variants in the favored acetate-forming
direction of the reaction revealed that a similar final level of inhibition of ~85-90% was
achieved for the variants and wild-type enzyme by 15 mM ATP (Figure 2.7A).
The IC50 value for ATP, defined as the concentration of ATP required to cause 50%
inhibition of enzymatic activity, was reduced for the EhACK variants versus the wild-type
enzyme (Table 2.4). The IC50 values were reduced 20-30% for the two Q323-M324 variants
versus the wild-type enzyme, whereas the quadruple variant in which both the Q323-M324
residues and the D272-R274 salt bridge were altered had an IC50 value that was reduced by
over 60%. Since ATP is a competitive inhibitor of EhACK activity, this increase in
inhibition suggests that the D272A-R274A-Q323G-M324I variant binds ATP more efficiently
than wild-type enzyme even though it cannot use it as a substrate.
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Figure 2.6: ATP is a competitive inhibitor of EhACK. Double reciprocal plot of EhACK
activity versus Pi concentration in the absence (○) or presence of 2.5mM (●), 5mM (□), or
7.5mM ATP (■). Activities are the mean ± SD of three replicates.
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Figure 2.7: Inhibition curves for EhACK and MtACK wild-type and variant enzymes.
Enzymatic activity was determined for each enzyme in the presence of the indicated
concentration of ATP or PPi. Activities were plotted as a percentage of the activity
observed for the wild-type enzyme in the absence of inhibitor. Activities are the mean ±
SD of three replicates. (A) ATP inhibition of EhACK and its variants in the acetate-forming
direction. EhACK wild-type, (○); EhACK Q323G-M324I variant (●); EhACK Q323A-M324A
variant, (□); EhACK D272A-R274A-Q323G-M324I variant (■). (B) and (C) PPi inhibition of
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MtACK and its variants in the acetate-forming (B) and acetyl phosphate-forming (C)
directions. MtACK wild-type, (○); MtACK G331Q-I332M variant (●)
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ATP IC50 (mM)
EhACK
Acetate-forming
direction
Wild-type 6.1 ± 0.05
Q323G-M324I 4.2 ± 0.30
Q323A-M324A 4.8 ± 0.09
D272A-R274A-Q323G-M324I 2.4 ± 0.19
PPi IC50 (mM)
MtACK
Acetate-forming
direction
Acetyl phosphate-
forming direction
Wild-type 3.3 ± 0.06 7.5 ± 0.28
G331Q-I332M 4.0 ± 0.28 14 ± 1.1
ND, not determined because the enzyme was inactive in this direction.
Table 2.4: IC50 values for ATP inhibition of EhACK and PPi inhibition of MtACK
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For MtACK, inhibition by PPi in the acetate-forming direction was similar for the
wild-type enzyme and the G331Q-I332M variant, with ~70% maximum inhibition observed
(Figure 2.7B). The IC50 values for PPi were similar for both enzymes (Table 2.4). PPi
inhibition in the acetyl phosphate-forming direction was much stronger, reaching greater
than 90% for both the wild-type and variant enzymes. However, maximum inhibition for
the wild-type enzyme was achieved at lower ATP concentration (20-25 mM versus 40 mM
for the variant). This is reflected in the IC50 value, which is nearly two-fold higher for the
G331Q-I332M variant than for the wild-type.
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DISCUSSION:
Substrate selection in ATP-utilizing ACKs
Thaker et al. (12), in analysis of the MtACK and EhACK structures, predicted that
Pi/PPi binding does not involve the adenosine pocket and PPi likely binds in a position
corresponding to the position of the β- and γ-phosphates of ATP in MtACK. Our inspection
of structures for the four Mycobacterium ACKs and the S. enterica ACKs in addition to
those for MtACK and C. neoformans ACK showed that the opening to the adenosine
pocket is not occluded in ATP-utilizing ACKs, only in the EhACK structure. Thus, we
investigated whether phosphoryl donor selection by ACK is based primarily on
accessibility of the adenosine pocket.
Alterations were made to MtACK to determine if the substrate specificity could be
changed from ATP to PPi if the adenosine pocket was occluded. Catalysis was greatly
reduced (~50-150 fold) in the enzyme variants and this was accompanied by increases in
the Km values for both acetate and ATP in the acetyl phosphate-forming direction of the
reaction. Gorrell et al. (16), using tryptophan fluorescence quenching, found that domain
closure occurs upon nucleotide binding. Thus, the effects of these alterations on MtACK
activity may be complicated to interpret as reduced catalysis could be due to inefficient
utilization of ATP and to an influence in domain closure. Notably though, substrate
specificity did not change and the MtACK variant was unable to utilize PPi as a substrate.
Thus, conversion of ATP-dependent MtACK to a Pi/PPi-dependent enzyme could not be
achieved by simple closure of the adenosine pocket.
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MtACK has a broad NTP substrate range (15, 17) with a preference for ATP and is
highly active in both the acetate- and acetyl phosphate-forming directions. Ingram-Smith
et al. (15) examined the roles of conserved active site residues in NTP substrate selection in
MtACK, and found that Gly331 in the ADENOSINE motif exerted a strong influence.
Asn211 in the PHOSPHATE2 motif and Gly239 in the LOOP3 motif were found to be
important for enzymatic activity but did not play a substantial role in NTP preference.
Yoshioka et al. (10) studied four residues in the ADENOSINE motif and one residue
in the PHOSPHATE2 motif of E. coli ACK for their role in ATP versus PPi substrate
determination. The candidate residues Asn213, Gly332, Gly333, Ile334 and Asn337 were altered
to the respective residues present in EhACK (Thr, Asp, Gln, Met, and Glu, respectively)
and the ability of the enzyme variants to utilize PPi in place of ATP was examined. All five
variants displayed increased Km for ATP and decreased catalysis but none was able to
utilize PPi.
Yoshioka et al. (10) also examined the distribution of the E. coli ACK candidate
residues and the corresponding residues in EhACK among 2625 ACK homologs. They
suggested that Asn337 (Glu327 of EhACK) is most important in determining substrate
selection as it is present in the ten ACK sequences most closely related to EhACK.
However, their kinetic results with the Asn337 variants are inconclusive in this regard,
although the kinetic results for this and other variants do strongly support a major role in
ATP binding for the ADENOSINE motif but do not delineate specific residues responsible
for determining ATP versus PPi utilization.
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Substrate selection in PPi-dependent EhACK
As a converse to our experiments with MtACK, we altered residues blocking the
opening to the adenosine pocket in EhACK to reduce the occlusion and evaluated the
enzyme’s ability to utilize Pi/PPi versus ATP/ADP. The EhACK variants exhibited
decreased activity with Pi and PPi, much as we expected. Although catalysis was reduced
for the Q323G-M324I and Q323A-M324A variants, further opening of the entrance to the
adenosine pocket in the D272A-R274A-Q323G-M324I variant almost completely eliminated
activity. This suggested that as the opening to the adenosine pocket increases, Pi and PPi
may still bind but their positioning may be suboptimal.
Although the enzyme variants were still unable to utilize ATP as a substrate, ATP
and ADP did inhibit enzyme activity. The level of inhibition increased as the opening to
the adenosine pocket was expanded, especially for the D272A-R274A-Q323G-M324I variant.
This suggested that ATP and ADP could now enter the adenosine pocket and interfere with
Pi binding. Such an interpretation of these results is supported by the observation that ATP
inhibition is competitive versus Pi.
The similar behavior of the Q323G-M324I and Q323A-M324A variants with respect to
inhibition by ATP indicated that the increased binding (as judged by IC50 values) must be
due to expanding the entrance to the adenosine pocket rather than a specific interaction
between the altered residues and ATP. Models of the enzyme variants indicated that these
alterations to the adenosine pocket would result in decreased impairment of ATP binding
(Figure 2.8). In particular, deletion of G203 to shorten the PHOSPHATE2 loop combined
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Figure 2.8: In silico modeling of the adenosine binding pocket of EhACK variants.
Models were built using Accelrys Discovery Studio version 3.5 (Biovia). ADP binding in
MtACK was superimposed into the EhACK structure models. (A) Q323G-M324I variant. (B)
D272A-R274A-Q323G-M324I variant. (C) G203- D272A-R274A-Q323G-M324I variant.
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with alteration of the ADENOSINE motif and removal of the D272-R274 salt bridge should
allow the pocket to accommodate ATP well (Figure 2.8C). Although the alterations made
to EhACK appeared to increase the enzyme’s ability to bind ATP, as indicated by the
inhibition results, ATP was still not an effective substrate.
Other possible PPi -dependent ACKs
Using a BLASTp search of the non-redundant protein sequence database at NCBI
with EhACK as the query sequence, we identified a small number of putative ACK
sequences that may also be PPi-dependent or require a substrate other than ATP or PPi.
Several of these putative ACK sequences came from metagenome analyses of anaerobic
digestors. However, there were four putative ACK deduced amino acid sequences that
came from draft genomes for the bacteria Ornatilinea apprima, Longilinea arvoryzae,
Flexilinea flocculi, and Leptolinea tardivitalis (18-21). These bacteria are all obligate
anaerobes from the phylum Chloroflexi within the family Anaerolineaceae. Three of the
four produce acetate as a main product from glucose fermentation; L. arvoryzae also
produces acetate as a primary fermentation product but from growth on sucrose instead of
glucose. Little else is known about these bacteria beyond their initial characterization for
recognition as new species.
Alignment of these putative ACK sequences with those of the four Entamoeba
ACK sequences (those from E. histolytica, Entamoeba nuttalli, Entamoeba dispar, and
Entamoeba invadens) revealed two key findings. Within the PHOSPHATE2 motif, all
eight of these sequences have the extended loop containing the second Gly residue (Figure
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2.9). These are the only putative ACK sequences identified to have this extended
PHOSPHATE2 loop (see Figure 1 for comparison). Within the ADENOSINE motif, all of
these sequences have a conserved Asp residue (immediately adjacent to Q323-M324 of
EhACK) that is not conserved in any other ACK sequences (all of which have Ala or Gly
at the equivalent position, as shown in Figure 2.1).  Interestingly, these bacterial ACKs
have a conserved Asp at the equivalent position to Gln323 of PPi-dependent EhACK and
the other Entamoeba ACKs. A completely conserved Gly resides at this position (Gly331
of MtACK) in all ATP-dependent ACKs. Whether this indicates that these enzymes are
neither ATP-dependent nor PPi-dependent, or whether there is some flexibility in the
identity of the residue at this position in PPi-dependent ACKs is unknown.
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Figure 2.9: Partial alignment of putative PPi-ACK amino acid sequences.
Sequences were aligned using Clustal Omega. The PHOSPHATE2 and ADENOSINE
motifs are shown. The full alignment is provided in the Figure 2.10. Abbreviations and
sequence accession numbers: E.his, E. histolytica, XP_655990.1; E.nut, Entamoeba
nuttalli, XP_008860710.1; E.dis, Entamoeba dispar, XP_001741606.1; E.inv, Entamoeba
invadens, XP_004254504.1; O.app, Ornatilinea apprima, WP_075061087.1; L.arv,
Longilinea arvoryzae, WP_075074878.1; F.flo, Flexilinea flocculi, WP_062279690.1;
L.tar, Leptolinea tardivitalis; WP_062422928.1.
PHOSPHATE2
E.his 193 KIIACHLGTGGSSCCGIV 210
E.nut 193 KIIACHLGTGGSSCCGIV 210
E.dis 193 KIIACHLGTGGSSCCGIV 210
E.inv 193 KIVACHLGTGGSSCCAIL 210
O.app 201 KIIACHLGTGGSSAVALK 218
L.arv 201 KLILCHLGTGGSSVVAMK 218
F.flo 201 KFILCHLGSGGSSITAVR 218
L.tar 201 KLILCHLGTGGSSVTAMK 218
* **** ****
ADENOSINE
E.his 317 LLVFTDQMGLEVWQVRKA 334
E.nut 317 LLVFTDQMGLEVWQVRRA 334
E.dis 317 LLVFTDQMGLEVWQVRKA 334
E.inv 317 MLVFTDQVGLEVPEVRKA 334
O.app 322 ALIFTDDIGLWSWQLRES 339
L.arv 323 AIVFTDDVGLKSWKLRAK 340
F.flo 323 AIVFTDDIGETSWKLREK 340
L.tar 323 AIVFTDDVGLKSWKLREK 340
***  * *
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____PHOSPHATE1_____
E.his MSNVLIFNVGSSSLTYKVFCSDN-----IVCSGKSNRVNVTGTEKPFIEHHLNGQIIKIE 55
E.nut MSNVLIFNVGSSSLTYKVFCSDN-----IVCNGKANRVNVTGTEKPFIEHHLNGKIIKIE 55
E.dis MSNVLIFNVGSSSLTYKVFCSDK-----IVCSGKANRVNVTGTTKPFIEHHLNGKVIKVE 55
E.inv MPHILVFNVGSSSLTYKLFENTK-----EIIKGKANRVNVTGAELPFIEHHINGKTITIE 55
O.app -MNLLVFNCGSSSLNYKVFSGDSNSTAQITAKGKAHRVGVKGSDPSFIEHHLSNQTVKET 59
L.arv -MNILIFNCGSSSQGFKVYQTSGHDQPVVLVSGKAKNVATQTRADAFIEWKSKISAGSQK 59
F.flo -MNILVFNCGSSSQGFKVYEVDQNHAEKVVISGKAKNVAARTQSQPYLFWNMNDKTEQKF 59
L.tar -MNILIFNCGSSSQGFKLYQKEYGTTPILVAAGKARNVATKTRADSCLDWTAGSQKGSVN 59
::*:** ****  :*::             **:..* .     . :  .
E.his TPILNHPQAAKLIIQFLKENHISIAFVGHRFVHGGSYFKKSAVIDEVVLKELKECLPLAP 115
E.nut TPILNHPQAAKLIIQFLKENHISIAFVGHRFVHGGSYFKKSAIIDEVVLKELKECLPLAP 115
E.dis TPTLNHQQAAEFIIQFLKENHVSIAFVGHRFVHGGSYFKRSAIIDEAVLKELKECLPLAP 115
E.inv TGPLNHQEAARLIIKFLKENKFTIDIVGHRFVHGGSYFKTSAVIEGPVLKELKSCIPLAP 115
O.app QPLETHAQAAERVLQNLRDHQIPIDAVGHRFVHGGAYFKESALLTEDTLARLTECLPLAP 119
L.arv TDLSSHRQAAGKIIAILKELQVSVDAIGHRFVHGGTFFDKTVQIDPPVLQKLQQCLPFAP 119
F.flo CDLSSHRLAAQEIIGILNAKGIQPDAIGHRFVHGGKLFQQTTRIDTNTRNLLIQCLPLAP 119
L.tar VELPSHREAARQILALLRKSNLSVDAIGHRFVHGGDVFQHTTRIDKAVLAGLKGCFPLAP 119
.*  **  ::  *.   .    :********  *. :. :   .   *  *:*:**
E.his IHNPSSFGVIEISMKELPTTRQYVAIDTAFHSTISQAERTYAIPQPYQS--QYLKFGFHG 173
E.nut IHNPSSFGVIEMSMKELPTTRQYVAIDTAFHSTISQAERTYAIPQPYQS--QYLKFGFHG 173
E.dis IHNPSSFSVIEVSMKELPTTKQYVAIDTAFHSTISQAERTYAIPQPYQS--QYLKFGFHG 173
E.inv IHNPASYSVIEVALTELPNTKQYVAIDTAFHSTINKTQRTYAIPEPFQS--QYLKFGFHG 173
O.app IHNPNSMSVIYTCLEHQPGCPQYVTFDTAFHAALPPEAYTYAVPQSIRDTHTYRRFGFHG 179
L.arv IHNPNSYSVIEVCLEQFPDVPQFAVFDTAFHARMPEVSKQYAIPRDLVEKYGYYKYGFHG 179
F.flo IHNPNSFSVIEVCEQLLPSIPQYAVFDTAFHSQMPESSARYAIPGSIAEKFGFRKYGFHG 179
L.tar IHNPNSYSVIEVCRELLPDAAQFAVFDTAFHANMPAESRQYALPRELVQENGYRKYGFHG 179
**** * .**  .    * *:..:*****: :  **:*  .  : ::****
____PHOSPHATE2____  ________LOOP3___
E.his LSYEYVINSLKNVID--VSHSKIIACHLGTGGSSCCGIVNGKSFDTSMGNSTLAGLVMST 231
E.nut LSYEYVINSLKNVID--VSHSKIIACHLGTGGSSCCGIVNGKSFDTSMGNSTLAGLVMST 231
E.dis LSYEYVINSLKNVID--VSHSKIIACHLGTGGSSCCGIVNGKSFDTSMGNSTLAGLVMST 231
E.inv LSYEFVLTSLKERMD--VDKLKIVACHLGTGGSSCCAILNGKSYDTSMGNSTLAGLVMST 231
O.app LSYHFVTQAAGPFLETPFSESKIIACHLGTGGSSAVALKNGVPLDTSMGFTPLPGLIMST 239
L.arv LSYQYVSSRMLELMGKPLEELKLILCHLGTGGSSVVAMKNGLPLDTSMGYSPLAGLVMST 239
F.flo LSYQYVSTKTAQLIGKPLQNSKFILCHLGSGGSSITAVRDGKSIDTSMGYSPLAGLVMSS 239
L.tar LSYQYVSARTAEYLGRPLEELKLILCHLGTGGSSVTAMKDGRSMDSSMGYSPLPGLVMST 239
***.:*       :  ... *:: ****:****  .: :* . *:*** :.*.**:**:
_______  ___LOOP4____
E.his RCGDIDPTIPIDMIQQVGIEKVVD-ILNKKSGLLGVSELSSDMRDILHEIETRGPKAKTC 290
E.nut RCGDIDPTIPIDMIQQVGIEKVVD-ILNKKSGLLGVSELSSDMRDILHEIEIRGPKAKTC 290
E.dis RCGDIDPTIPIDMIQQVGVERVVD-ILNKRSGLLGVSELSSDMRDILHEIEIKGPKAKTC 290
E.inv RCGDIDPSIPINIVEQIGIQKTVD-LLNKRSGLFGVSETSCDIRDLLKEIKENGQKAEKC 290
O.app RTGDLDAQIPIQLLKEGKSPKEIETLLNKKSGLLGISQFSSDLRDILARVE----QDPNA 295
L.arv RSGDIDPEIVLEMIRNGSSPDEVSQILNNRSGLIGLSGFSSSLPEIIEASE---KGNADC 296
F.flo RSGDLDPEIILDLVRSGYSADEVSRILNRESGLIGLSGFSSNLAEIIDAAE---SGNVSC 296
L.tar RCGDLDPEIVLEMIRRGSSVDDVEFILNNQSGLIGLSGYSSNLEEVIAEGE---KGNEDC 296
* **:*. * ::::.       :. :**..***:*:*  *..: :::   :        .
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Figure 2.10: Alignment of putative PPi-ACK sequences. The full ACK sequence
alignment from which Figure 2.9 was derived is shown.
_____ADENOSINE____
E.his QLAFDVYIKQLAKTIGGLMVEIGGLDLLVFTDQMGLEVWQVRKAICDKMKFLGIELDDSL 350
E.nut QLAFDVYIKQLAKTIGGLMVEIGGLDLLVFTDQMGLEVWQVRRAICDKMKFLGIELDDSI 350
E.dis QLAFDVYIKQLAKTIGGLMVEIRGLDLLVFTDQMGLEVWQVRKAICDKMKFLGIELDNSL 350
E.inv ALAFDLYINQLTKTIGGLMVEIGGLDMLVFTDQVGLEVPEVRKAVCNKLEFLGVELDSEK 350
O.app HLAFEMAVHRLVKYIGAYAVLLGGLDALIFTDDIGLWSWQLRESVCQGLTWCGIAIDPTA 355
L.arv QLAYDVYAHRLETYLGAYTWLLDGADAIVFTDDVGLKSWKLRAKVCGGVQNLGVEIDAAK 356
F.flo QIAFDVYAQRLMEYMGAFYWLLNGADAIVFTDDIGETSWKLREKLFGGKDLLGVKLDQEL 356
L.tar RLAFDVYAHRLQLYLGAFFWLLNDADAIVFTDDVGLKSWKLREKVCRGVENLGILLDADA 356
:*:::  ::*   :*.    : . * ::***::*    ::*  :       *: :*
E.his NEKSMGKKIEFLTMPSSKVQVCVAPNDEELVILQKGKELFQF------ 392
E.nut NEKSMGKKIEFLTMPSSKVQVCVAPNDEELVILQKGKELFQF------ 392
E.dis NEKSMGKKIEFLTTPSSKVQVCVAPNDEELVILQKGKELFQF------ 392
E.inv NEKSRGKEIEFISTEKSRMKICVVPNDEELVILKKGSELFQFCN---- 394
O.app NREAPYDRITPIEAPDSRARVLVIPTDEEWVIGQEGFALLQEGRHAYH 403
L.arv NVNAPLDRASRVSSARSKTQIWVMPTDEESVILQEILAQFCLA----- 399
F.flo NRQATGSKPSCISQEGSKTQIWVIPTDEEIVILNEVRAIIG------- 397
L.tar NRLALPDQITCFSSPASRTRLLTVPTDEEQVILQEVLSQLEQA----- 399
*  :  ..   .    *: :: . *.*** ** ::    :
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CONCLUSIONS:
Our results demonstrate that phosphoryl donor specificity in ACK is mediated not
just by access to the adenosine binding pocket but by other elements as well, as simple
opening or occlusion of the entrance to this pocket was not sufficient to alter substrate
specificity. This suggests that the active sites of the ADP/ATP-dependent and Pi/PPi-
dependent enzymes have evolved to optimize utilization of their preferred substrate at the
expense of the ability to use alternative substrates, and thus better suit their biological
function.
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CHAPTER III
THE ROLE OF ADP-FORMING ACETYL-COA SYNTHETASE
AND ACETATE KINASE IN ENTAMOEBA HISTOLYTICA
Thanh Dang, Diana Nguyen, Cheryl Jones, and Cheryl Ingram-Smith
ABSTRACT:
Entamoeba histolytica is a human pathogenic protozoan that causes
approximately 90 million cases of amoebic dysentery, resulting in 50,000 – 100,000
deaths annually. This amitochondriate parasite lacks many essential biosynthetic
pathways including the TCA cycle and oxidative phosphorylation. As a result, substrate
level phosphorylation plays a necessary and important role in ATP production. E.
histolytica produces ethanol and acetate as the major end products during growth, of
which acetate can be generated by acetate kinase (EhACK) and ADP–forming acetyl–
CoA synthetase (EhACD). ACK converts acetyl phosphate + orthophosphate to acetate +
pyrophosphate (PPi). Biochemical and kinetic characterization of recombinant EhACK
showed that it strongly prefers the acetate/PPi forming direction. On the other hand,
recombinant EhACD displays high activity in both directions to convert acetyl-CoA +
orthophosphate + ADP to acetate + ATP + CoA. Using reverse genetics, both EhACK
and EhACD were shown to play a role in E. histolytica proliferation. An acd knockdown
strain displayed a growth defect in normal high glucose media, or when exposed to
bovine serum starvation. Metabolite analysis substantiated EhACD’s role to extend
glycolysis for ATP generation and linked reduced growth of the acd knockdown to ATP
availability. Moreover, EhACD was found to be essential for growth on propionate,
101
suggesting a role in propionate activation as carbon source. EhACK also shared signs of
involving in growth during stress conditions; the ack knockdown strain showed enhanced
growth in medium lacking tryptone and low in glucose. Thus, EhACK may play a role in
growth under stress conditions and unlikely plays a role in glycolysis.
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INTRODUCTION:
Entamoeba histolytica is an amoebic parasite that infects an estimated 90 million
people worldwide and causes approximately 100,000 deaths per year (1-3). Infection
proceeds through an oral-fecal route, resulting in E. histolytica colonization within the
large intestine. This amitochondriate parasite lacks many essential biosynthesis pathways
including the TCA cycle and oxidative phosphorylation; thus, ATP generation is limited
to glycolysis (4-6).
Unlike the standard glycolytic pathway, E. histolytica glycolysis is pyrophosphate
(PPi)-dependent. Instead of ATP–dependent phosphofructokinase and pyruvate kinase, E.
histolytica possesses pyrophosphate–dependent phosphofructokinase (PPi-PFK) and
pyruvate phosphate dikinase (PPDK) (Figure 3.1). Pyrophosphate, therefore, plays an
important role in energy conservation. Ultimately, E. histolytica produces ethanol and
acetate as the major end products during growth on glucose, of which acetate can
generated by acetate kinase (EhACK) and ADP–forming acetyl–CoA synthetase
(EhACD).
Acetate kinase (ACK; EC 2.3.1.8) is a phosphotransferase that interconverts
acetyl phosphate and acetate. Widespread in bacteria, acetate kinase primarily function to
generate ATP or activate acetate by partnering with another enzyme, commonly
phosphotransacetylase (PTA) (7, 8). ACK has also been identified in one genus of archaea,
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Figure 3.1: Entamoeba histolytica extended glycolytic pathway. This schematic depicts
E. histolytica PPi-dependent glycolysis in which phosphofructokinase (PFK) and
pyruvate kinase (PK) are replaced with PPi-dependent PFK and pyruvate phosphate
dikinase (PPDK). ACD and the bifunctional aldehyde-alcohol dehydrogenase (ADHE)
extend the glycolytic pathway to produce ethanol (EtOH) and acetate, which can also be
produced by ACK.
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other eukaryotic microbes, several fungi, and E. histolytica (9, 10). EhACK was shown to
be pyrophosphate and inorganic phosphate dependent, a stark contrast to all other
characterized ACKs which are ATP and ADP dependent (9, 11). Kinetic analysis also
demonstrated that EhACK operates primarily in the acetate-producing direction in vitro.
Consistent with this, activity was detected only in the acetate/PPi – direction in cell
extract, supporting this as the physiological direction of EhACK (11). However, ACK’s
role in E. histolytica remains undefined.
EhACK was hypothesized to provide supplemental pyrophosphate for the
pyrophosphate-dependent glycolysis in E. histolytica (11). In a comparison between the
transcriptome of the virulent HM–1:IMSS and the nonvirulent Rahman strains, several
glycolytic enzymes including PPi–PFK were found to be highly upregulated in HM–
1:IMSS in both axenic culture and during contact with human colon explant (12). This
upregulation was thought to reflect the carbon metabolism needs during colonic mucosa
degradation and tissue destruction during intestinal amoebiasis. EhACK was
constitutively expressed in active trophozoites and at a slightly higher level in HM–
1:IMSS versus the Rahman strain (13, 14). These findings supported the possibility that
EhACK could work in unison with PPi–dependent phosphofructokinase and pyruvate
phosphate dikinase to drive glycolysis.
ACD (EC 6.2.1.13) catalyzes the conversion of acetyl-CoA to acetate to generate
ATP. Current knowledge of ACD comes from in vitro biochemical and kinetic
characterization of eukaryotic ACDs from E. histolytica (15), Giardia lamblia (16) and the
archaeal Pyrococcus furiosus ACD (17, 18). ACD is believed to play a critical role in
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conservation of energy by extending the glycolytic pathway, generating additional ATP
and recycling CoA(19). In vitro kinetic analysis of recombinant EhACD also showed this
enzyme catalyzes a reversible reaction, indicating potential alternative roles in vivo (15).
Based on these kinetic analyses, this enzyme may function in acetate activation during
nutrient limiting conditions as seen with AMP-forming acetyl-CoA synthetase (7, 15). Acd
also appears to be constitutively expressed (14), suggesting that this enzyme may be
essential in energy metabolism, survival, or proliferation. However, its significance has
yet to be investigated in depth.
A majority of E. histolytica infections reside within the human colon, where
glucose is limiting. Alternative carbon sources and energy conservation thus can be
plausibly seen as an essential part of E.  histolytica survival and growth. Here, we
investigated the functional role and contribution of EhACK and EhACD in growth,
survival and adaptation to nutrient limiting environments. Our study showed that EhACD
enhanced E. histolytica proliferation and suggested EhACK may hold a novel role in
vivo.
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MATERIALS AND METHODS:
Chemicals and reagents
Chemicals were purchased from Qiagen, Promega, Sigma-Aldrich, VWR
International, Gold Biotechnology, Fisher Scientific, Gemini Bio-products, EMD
Millipore, and Life Technologies. Penicillin-streptomycin and Diamond vitamins from
Life Technologies (Carlsbad, CA) and heat inactivated adult bovine serum from Gemini
(Sacramento, CA) were used for all Entamoeba media culture. Restriction enzymes were
purchased from New England Biolabs (Ipswich, MA). Primers were purchased from
Integrated DNA Technologies (Coralville, IA).
Strains and culture conditions
E. histolytica HM-1:IMSS was grown axenically in Diamond’s TYI-S-33
medium(20) (17.95 g tryptone, 9.66 g yeast extract, 9.2 g glucose, 1.84 g NaCl, 0.92 g
K2HPO4, 1.15 g cysteine, 0.178 g ascorbic acid, 0.0194 g ammonium ferric chloride, 15%
v/v adult bovine serum, 1.73% v/v penicillin-streptomycin, and 2.62% v/v Diamond
vitamins per liter at pH 6.8) under standard conditions at 37°C. Log phase trophozoites
were harvested and used for all experiments. Modifications to TYI-S-33 medium were as
follows: reduced glucose, 10 mM glucose; tryptone exclusion, no added tryptone;
tryptone exclusion + low glucose, no added tryptone and glucose; reduced adult bovine
serum, 3.85% adult bovine serum; and adult bovine serum excluded. Growth on acetate,
propionate, or butyrate was performed in TYI-S-33 medium with no added glucose and
supplemented with 63 mM acetate, 24 mM propionate, or 23 mM butyrate.
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Growth curves were determined for wild-type (WT), pKT3M-luciferase (LUC),
EhACK knockdown (EhACKkd) and EhACD knockdown (EhACDkd) strains. Trypan
blue exclusion (28) was used to distinguish viable from dead cells and viable cells were
counted every 24 hours using a Luna Automated counter (Logos Biosystem, Annandale,
VA). Cultures for growth determinations were grown at 37°C in base TYI-S-33 medium
with the following alterations: normal high glucose, reduced glucose, low glucose,
tryptone exclusion, tryptone exclusion + low glucose, reduced adult bovine serum, and
adult bovine serum exclusion (Table 3.1).
Construct cloning and transfection
Primers used are listed in Table 3.2. The full length Entamoeba histolytica ACK
(EHI_170010) and ACD (EHI_178960) coding sequences were PCR-amplified from E.
histolytica genomic DNA using KOD hot start polymerase (EMD Millipore, Billerica,
MA). E. hisotlytica genomic DNA was isolated from 2 x 106 trophozoites using Wizard
genomic DNA isolation kit (Promega, Madison, WI). EhACK and EhACD RNAi
constructs were created by cloning the amplified products into the modified pKT3M
vector in place of the resident luciferase gene using the AvrII and XhoI restriction
enzymes (21). All final constructs were confirmed by Sanger sequencing at the Clemson
University Genomics Institute (CUGI). E. histolytica trophozoites were transfected with
the RNAi constructs by electroporation as described previously (22, 23). Briefly, a total of
2.4 x 106 cells were electroporated with 100µg of DNA using two consecutive pulses at
1.2kV and 25uF. Transfectants were selected after two days by adding 6µg/mL G418 into
the medium. Stable transfectants were maintained under G418 selection.
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Conditions Glucose(mM)
Tryptone
(% w/v)
Adult bovine serum
(% v/v)
Normal high glucose 50 2.2 15
Reduced glucose 10 2.2 15
Low glucose Not added 2.2 15
Tryptone exclusion 50 Not added 15
Tryptone exclusion + low glucose Not added Not added 15
Reduced adult bovine serum 50 2.2 3.85
Adult bovine serum exclusion 50 2.2 Not added
Table 3.1: List of glucose, tryptone, and adult bovine serum alterations to standard
TYI-S-33 medium. Bolded texts illustrate the alteration within the specific condition.
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Primer Sequences
Cloning primers
EhACK RNAi Forward 5’ CTACCTAGGATGTCTAACGTACTAATATTCAAC G
EhACK RNAi Reverse 5’ CTACTCGAGTTAAAACTGAAATAATTCTTTTCCTTT TTGTAA
EhACD RNAi Forward 5’ACACCTAGGATGCAATTTGAGCCACTCTTCAATCC
EhACD RNAi Reverse 5’ ACACTCGAGTTATGGTTGGATGACGAGGTGAGAG
RT-PCR primers
EhACK RTPCR Forward 5’ AGGGTAAATGTTACAGGAACAGA
EhACK RTPCR Reverse 5’ TGGTGCCACACAAACTTGAAC
EhACD RTPCR Forward 5’ AGTGCCGGTTATTGGTGCAT
EhACD RTPCR Reverse 5’ AGCTTCAGCAACTGCTTCGT
ssrRNA Forward 5′-AGGCGCGTAAATTACCCACTTTCG
ssrRNA Reverse 5′-CACCAGACTTGCCCTCCAATTGAT
Table 3.2: List of primers used for RNAi construct generation and RT-PCR confirmation.
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Reverse transcriptase-PCR (RT-PCR)
Primers are listed in Table 3.1. RNA was isolated from 2 x 106 trophozhoites
using the RNeasy mini kit (Qiagen, Valencia, CA). RT-PCR was employed to determine
whether the Ehack and Ehacd were silenced by the respective RNAi constructs. RT-PCR
was performed using the One-step RT-PCR kit (Qiagen). RNA levels were normalized
for comparison using the small subunit ribosomal RNA gene (accession number:
X61116) as previously described (24).
Enzyme assays
Ehack and Ehacd knockdowns were confirmed by measuring ACK and ACD
activity, respectively, in cell lysates. A total of 4 x 106 cells were harvested by
centrifugation and washed twice in phosphate buffered saline (PBS). Cells were
resuspended in 25 mM Tris, 150 mM NaCl (pH 7.4). Cells were lysed by vortexing with
acid-washed beads for one minute, followed by 1 minute on ice. This cycle was repeated
3 times. The lysates were centrifuged at 5000 x g for 15 minutes and the supernatant was
retained.
ACK activity was measured using the reverse hydroxamate assay as previously
described (25). Enzyme activity was assessed in a 300 µl reaction containing 50 mM
sodium phosphate, 2 mM acetyl phosphate, 100 mM Tris-HCl (pH 7), and 10 mM MgCl2
and 50 µl cell lysate for 30 minutes at 37oC before quantification. Reactions were
terminated by adding 100 µl of the development solution (0.92 M trichoroacetic acid, 250
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mM FeCl2, and 2.5 N HCl). Absorbance at 540 nM was measured using a Synergy Epoch
microplate reader (Biotek, Winooski, VT).
ACD activity in the acetyl-CoA forming-direction and acetate forming-direction
were measured as described by Jones and Ingram-Smith (15). ACD activity was
quantitated using 10 µl of cell lysate at 37oC for 15 minutes. For the acetyl-CoA forming-
direction, the hydroxamate assay was used at substrate saturating concentrations.
Reaction contained 1 mM CoA, 20 mM Mg:ATP, 100 mM acetate, and 50 mM Tris-HCl
(7.3). Absorbance at 540 nm was measured using a Synergy Epoch microplate reader. For
the acetate forming-direction, the DNTB assay was employed. Reactions contained 50
mM Tris-HCl (pH 7.3), 300 µM 5,5-dithio-bis-2-nitrobenzoic acid (DNTB), 300 µM
acetyl-CoA, 8 mM potassium phosphate, and 5 mM Mg:ATP. Assays were performed
using 96-wells plate in 200 µl reaction volume. The change in absorbance at 412 nm was
determined using Synergy H1 microplate reader.
Total protein concentration in cell lysates was measured using the Bradford assay
(26, 27) with bovine serum albumin as the standard.
Intracellular metabolite analysis
E. histolytica intracellular metabolites were extracted using an adapted methanol
extraction method (29) from 1 x 106 log phase trophozoites. Cells were harvested by
centrifugation, washed three times in ice cold 5% mannitol solution, and resuspended in
1500 µl of 100% methanol (-20oC). Trophozoites were lysed using a freeze-thaw method.
Cells were frozen in liquid nitrogen for 5 minutes and thawed on dry ice for 10 minutes.
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This cycle was repeated 3 times. The lysate was centrifuged at 13,000 rpm for 5 minutes
and the supernatant isolated. Samples were analyzed at Clemson Multi-Users Analytic
Lab via LC-MS/MS. Intracellular metabolite concentrations were calculated by assuming
E. histolytica trophozoites have an intracellular volume of 1.3 µl per 1 x 106 cells as
previously reported (30, 31).
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RESULTS:
Ehacd silencing affects growth on glucose but Ehack silencing does not
To examine the roles of EhACK and EhACD, reverse genetics was employed.
The ack and acd genes were individually silenced using the trigger-RNAi gene silencing
system developed by Morf et al. (21). The ack and acd coding regions were cloned into the
modified pKT3M trigger-derived antisense small RNA vector. The pKT3M vector
containing a luciferase gene (luc) was used as a transfection control. RNA was isolated
from wild type, luc control, and the ack and acd silenced strains and RT-PCR was
performed to examine RNA levels for the silenced genes. ack and acd mRNA levels
were undetectable in the respective silenced strains (Figure 3.2A and B) but were
unaffected in the wild-type and luc control strains. In addition, ACK and ACD enzyme
activity was considerably reduced or abolished in ack and acd silenced cells, respectively
(Figure 3.2C-E). Taken together, this confirmed the successful silencing of these two
genes.
The ack and acd gene silenced strains, hereafter referred to as EhACKkd and
EhACDkd, both remained viable. EhACDkd grew slower than control cells (WT and
LUC) in standard TYI-S-33 medium containing 50 mM glucose (Figure 3.3A); This
difference in growth was statistically significant by 72 and 96 hours. However, the
EhACKkd strain grew at a comparable rate to the WT and LUC strains.
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Figure 3.2: EhACK and EhACD silencing by trigger antisense-derived RNA
interference. RT-PCR depicting Ehack mRNA levels (A) and Ehacd mRNA levels (B).
Control (X61116) shows RT-PCR of the small subunit RNA gene and indicates
equivalent mRNA in all lanes. C: EhACK activity from cell extracts in the acetate-
forming direction. D: EhACD activity from cell extracts in the acetyl-CoA forming
direction. E: EhACD activity from cell extracts in the acetate-forming direction. WT:
untransfected cells; LUC: luciferase control cells; EhACKkd: ACK knockdown cells;
EhACDkd: ACD knockdown cells. Enzyme activities are the mean ± SD of at least three
replicates. Specific activities are represented as a percentage of the activity observed
from the wild-type strain.
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Figure 3.3: E. histolytica growth in varying glucose concentration. Growth was assessed
by direct cell counting, using tryphan blue exclusion to indicate live versus dead cells.
Growth curves were initiated with 5 x 104 cells per tube. Cells were grown in TYI-S-33
medium containing (A) 50 mM glucose (the standard glucose concentration in this
medium), (B) 10 mM glucose, or (C) no added glucose. Cell numbers are the mean ± SD
of at least three biological replicates. The significance of the growth deficiency for the
ACDkd strain versus the WT and LUC strains was tested using a one-way ANOVA and
TUKEY separation of means with R. * = p-value ≤ 0.05.
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We next tested whether this difference in growth for the EhACDkd strain would
persist at lower glucose concentrations. The EhACDkd strain still showed the slowest
growth when the glucose concentration was reduced to 10 mM (Figure 3.3B). However,
this growth defect disappeared when EhACDkd cells were grown in TYI-S-33 medium in
the absence of added glucose (Figure 3.3C). The EhACKkd strain showed no difference
in growth from the WT and LUC control cells in the presence of 10 mM glucose (Figure
3.3B) and therefore growth was not assessed in the absence of added glucose.
Intracellular metabolite levels are affected in EhACDkd and EhACKkd strains
Intracellular acetyl-CoA and ATP concentrations were measured for the WT,
LUC control, EhACDkd, and EhACKkd strains after growth in TYI-S-33 medium
containing 50 mM glucose. Both the EhACDkd and EhACKkd strains showed an
accumulation of acetyl-CoA of approximately 172% vs. WT or LUC (Figure 3.4).
Consistent with the proposed role of ACD in acetate production from acetyl-CoA, the
EhACDkd strain proved to have a substantially reduced ATP pool that was
approximately 20% that observed for the EhACKkd, LUC, and WT strains.
Since the EhACDkd phenotype changed with glucose concentration, we examined
whether ACD activity in wild-type cells varied with changes in glucose concentration in
the growth medium. EhACD activity was examined in WT cells grown in TYI-S-33
medium containing 50 mM (standard), 10 mM, or no added glucose. ACD activity
remained constant in both the acetate-forming and acetyl-CoA-forming direction
regardless of glucose concentration (Figure 3.5).
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Figure 3.4: Acetyl-CoA and ATP level comparison between each E. histolytica cell
line. Cell extracts were prepared from 1 x 106 cells at 72 hours of growth. Samples were
analyzed via LC-MS/MS. Intracellular metabolite concentrations were normalized to the
concentration in WT cells which are ATP 0.86 ± 0.09 mM and acetyl-CoA 0.22 ± 0.03
mM (n = 6). The statistical significance of metabolite concentration vs. WT cell
intracellular concentration were tested using a Welch two samples T-test in R. * = p-
value < 0.001.
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Figure 3.5: ACD activity from WT cells grown at varying glucose concentrations.
Cells were grown for 48 hours in TYI-S-33 medium and cell extracts were prepared for
measurement of enzymatic activity. A: ACD activity in the acetyl-CoA forming
direction. B: ACD activity in the acetate-forming direction. Enzyme activity was
measured at saturating substrate concentration. Activities are the mean ± SD of at least
three replicates.
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EhACK and EhACD expression and activity are independent from each other
If EhACK and EhACD have related roles, changes in expression or activity of one
might be expected to influence expression or activity of the other. To this end, EhACK
and EhACD activities were compared between the wild-type, LUC control, EhACKkd,
and EhACDkd strains. Enzyme activity in cell extract from each strain showed no change
in ACK activity when acd was silenced and vice versa (Figure 3.6). Thus, EhACK and
EhACD do not appear to be co-regulated.
EhACD plays a role in propionate utilization
The human colon, where E. histolytica colonizes, contains low to no glucose but
does have abundant level of short chain fatty acids (110-120mM), mainly as acetate,
propionate and butyrate with relative molar mass ratio of 57:22:21 (32), respectively.
Certain anaerobic microbes can switch from producing acetate to utilizing acetate as a
carbon source when necessary, termed the “acetate switch” (7). Kinetic analysis of
EhACD showed it can interconvert acetyl-CoA and acetate at relatively similar rates for
each direction of the reaction (15), suggesting EhACD may be able to utilize acetate as a
growth substrate under some conditions as well as produce it during growth on glucose.
WT, LUC, EhACDkd, and EhACKkd strains were grown in low glucose and the
presence of 63 mM acetate, 24 mM propionate, or 23 mM butyrate for 72 hours.
120
Figure 3.6: ACK and ACD activity in WT and gene silenced strains. The wild-type,
LUC control, and ACDkd and ACKkd strains were grown in standard TYI-S-33 medium
for 72 hours and ACD and ACK activities were determined in cell lysates. A: ACK
activity from cell lysate in the acetate -forming direction. B: ACD activity from cell
lysate in the acetyl-CoA forming direction. Activities are the mean ± SD of at least three
replicates.
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Figure 3.7: Growth in low glucose (Glu) TYI-S-33 media with or without short chain
fatty acid supplementation. Cells were grown 72 hours in media without
supplementation or supplemented with 63 mM acetate (Ac), 23 mM propionate (Prop), or
24 mM butyrate (But). Growth was initiated with 5 x 104 cells. Cell numbers are the
mean ± SD of at least three biological replicates.
A B
*
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For each strain, growth in butyrate or acetate supplemented media was comparable to that
observed in the absence of glucose or short chain fatty acid. Intriguingly, strains showed
improved growth on propionate supplemented media improved growth, with the
exception of the EhACDkd strain (Figure 3.7).
The EhACKkd strain grows in medium lacking glucose and tryptone
Studies have shown amino acids may also act as a substrate for energy
metabolism in E. histolytica (5, 6). To investigate this, we examined growth in TYI-S-33
media lacking tryptone, which is a source of free amino acids. As expected, omission of
tryptone resulted in substantial reduction in growth of the WT and control LUC strains as
well as the EhACKkd and EhACDkd strains (Figure 3.8A). Surprisingly, when glucose
was also omitted from the medium, EhACKkd cells showed a significant growth
advantage versus WT, LUC control, and EhACDkd strains (Figure 3.8B). Minimal
growth of these latter strains was observed and cell death was observed by 96 hours.
Growth under other nutrient limiting conditions is also affected
Since E. histolytica encounters various environments during infection, growth
was also examined under several other nutrient limited conditions. E. histolytica exposure
to serum in the colon, which is the primary site of infection, is unlikely. Therefore, we
examined growth in the absence of adult bovine serum and found that all strains died
(data not shown), indicating a requirement for adult bovine serum for in vitro growth in
culture. Next, growth in medium containing reduced serum levels of 3.85% (v/v) instead
of the 15% (v/v) serum concentration in standard TYI-S-33 medium was measured. Slow
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growth was observed for the WT, LUC, and EhACKkd strains cultured in the reduced
serum medium (Figure 3.9). However, the EhACDkd strain did not proliferate and
showed signs of death by 48 hours (Figure 3.9).
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Figure 3.8: Growth of E. histolytica WT and gene silenced strains in TYI-S-33 medium
lacking tryptone or glucose and tryptone. A: Growth in medium lacking tryptone. B:
Growth in medium lacking tryptone and glucose. Cell counts are the mean ± SD of at least
three biological replicates. The statistical significance of differences in growth between the
EhACKkd versus WT and LUC control strains was tested using a one-way ANOVA and
TUKEY separation of means in R. * = p-value ≤ 0.01.
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Figure 3.9: Growth during serum starvation. Strains were cultured in TYI-S-33
medium containing reduced (3.85% versus standard 15%) adult bovine serum. Growth
was initiated with 5 x 104 cells. Cell counts are the mean ± SD of at least three biological
replicates. The significance of the growth deficiency for the EhACDkd strain versus the
WT and LUC strains was tested using a one-way ANOVA and TUKEY separation of
means with R. * = p-value < 0.00001.
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DISCUSSION:
The two major metabolites produced during E. histolytica axenic growth on
glucose are ethanol and acetate. In the colon, the main site for E. histolytica infection,
glucose concentrations are low; however, short chain fatty acids are abundant with
acetate having the highest molar mass ratio (32). Acetate metabolism has been extensively
studied in prokaryotes, most notably in Escherichia coli, to have a role in ATP
generation, coenzyme A recycling, and acetate activation for utilization as a carbon
source when necessary (7). In bacteria, ACK typically partners with the enzyme
phosphotransacetylase to interconvert acetate and acetyl-CoA. The other common
enzyme which interconverts acetate and acetyl-CoA is AMP-forming acetyl-CoA
synthethase (ACS), which is thought to operate only in the acetyl-CoA forming direction.
These two pathways form the “acetate switch” (7) where interchange between acetate
production and utilization occurs to accommodate the cell’s needs (8, 33-36).
In E. histolytica, ACK and ACD are two acetate-producing enzymes and ACS is
not present. Even though ACD and ACS are not related, the fact that both are capable of
activating acetate to acetyl-CoA makes it plausible that ACD plays an analogous
physiological role to ACS. In the same manner, although EhACK deviates from other
ACKs in phosphoryl substrate usage (PPi versus ATP), it may still retain a parallel role to
other ACKs. Gene expression studies have shown that both ACD and ACK are
constitutively expressed in E. histolytica at moderate and low levels, respectively (14, 37).
This suggests these two enzymes may be an essential part of E. histolytica biology.
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The role of EhACD in growth on glucose
Gene silencing of EhACD indicated this enzyme is involved in E. histolytica
growth and proliferation. The EhACDkd strain exhibited significant growth reduction in
normal high glucose media versus the wild-type (Fig. 3.3A). Metabolite analysis revealed
that intracellular ATP levels decreased and acetyl-CoA increased, consistent with our
previous hypothesized role for ACD in extending the glycolytic pathway to produce ATP
by converting acetyl-CoA to acetate.
A previous study by Pineda et al. also looked at the effects of ACD gene silencing
in E. histolytica (31). Although they did detect reduced acetate production and a decrease
in intracellular CoA levels, there was no effect on intracellular ATP levels. The authors
concluded that ACD plays a role in CoA recycling during oxidative exposure but rejected
a role for ACD in ATP production. These results conflict with our current results.
However, this difference may be explained by the fact that Pineda et al. only achieved
partial gene silencing of ACD (~10-50%) (31) as compared to our current study in which
the ACD gene was effectively silenced and neither acd RNA nor enzymatic activity was
detectable. In addition, they neglected to measure growth differences in the gene silenced
strains versus the WT.
Although the EhACDkd strain grew more slowly than the wild-type at high (50
mM) glucose, both strains exhibited similar growth as the glucose concentration in the
medium was decreased (Fig. 3.3). ACD activity in extracts of wild-type cells grown in
varying glucose concentrations was found to be unchanged. This indicated that ACD was
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not regulated by glucose availability and the reduced growth of the wild-type strain at
low glucose was not due to changes in ACD activity. Instead, the impact of the reduced
glucose concentration on growth must be due to other reasons. One possible explanation
is that less acetyl-CoA is produced under these conditions, thus reducing substrate
availability for ACD and subsequently reducing ATP production via this route.
Role of EhACD in growth on other substrates
Another important aspect of acetate metabolism is acetate utilization. In vitro
characterization of EhACD showed this enzyme can function equally well in both
directions and can also utilize propionate and propionyl-CoA as substrates (15). Moreover,
E. histolytica naturally inhabits a large intestine environment low in glucose but enriched
with acetate, propionate, and butyrate (approximately 63 mM, 24 mM, and 23 mM,
respectively) (32). Growth analysis showed neither acetate nor butyrate improved E.
histolytica proliferation in TYI-S-33 medium lacking glucose. However, addition of
propionate improved E. histolytica growth (Fig. 3.7). More strikingly, the EhACDkd
strain did not show this improved growth upon propionate addition, indicating E.
histolytica can utilize propionate but not acetate as a growth substrate and that EhACD is
required for this.
Role of EhACK in E. histolytica
Like E. histolytica, Toxoplasma gondii also possesses a PPi oriented glycolytic
pathway. Pace et al.(38) demonstrated an increase in glycolytic activity and flux when
pyrophosphatase was overexpressed, indicating a regulatory role of PPi in glycolysis. If
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EhACK supplies a significant pyrophosphate for glycolysis, EhACKkd cells would be
expected to experience a decrease in glycolytic activity, leading to reduced growth or
growth abnormalities. At lower glucose concentrations, this effect would worsen if ATP
production and conservation was further impaired by disruption of EhACK activity.
However, this was not the case as EhACKkd cells grew normally under standard
conditions and in reduced glucose medium. This further argues against EhACK’s role as
a significant PPi provider for glycolysis.
In vitro kinetic analysis showed PPi-PFK and PPDK to have Km values of 50µM
and 470µM for PPi, respectively (39). The intracellular PPi concentration in E. histolytica
is estimated to be 0.41 – 0.7 mM (31, 40). One study reported knockdown of EhACK
(approximately 30-60% knockdown) only minimally decreased the overall concentration
of glucose-6-phosphate, fructose-6-phosphate, and pyrophosphate (31). Thus, EhACK may
contribute to the PPi pool but at a marginal level that may not affect the overall activity of
PPi-PFK and PPDK.
EhACD vs. glucose availability & EhACD vs. EhACK activity
Enzyme activity from cell extract was also examined to determine if EhACD and
EhACK have overlapping physiological functions. If these enzymes had overlapping
roles, manipulation of one enzyme may influence regulation of the other enzyme to
compensate. However, no significant association was observed between the two enzymes
(Fig. 3.6). This is consistent with current knowledge based on in vitro kinetic analysis
and the biochemical reaction associated with each enzyme.
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E. histolytica growth at limiting nutrient conditions
Entamoeba invadens, a close relative of E. histolytica that infects reptiles, also
possesses an ACD. Byers et al. (41, 42) reported that exposures to short chain fatty acid
(SCFA) inhibited encystation and ploidy level in E. invadens. Further investigation
showed Entamoeba uptakes SCFA in a pH-dependent manner and causes hypoacetylation
of histone H4 (43). In yeast, AMP-acetyl-CoA synthetase (ACS) involvement in histone
acetylation has also been reported. Eisenberg et al. (44) demonstrated cytosolic
accumulation of acetate leads to ACS activation and triggering of histone acetylation in
Saccharomyces cerevisiae. This relation between ACS and acetylation had also been
reported in mice and human (45, 46). EhACD, therefore, may be the connection between
SCFA, histone acetylation and encystation. However, investigation into this link is
limited by the undetectable level of histone acetylation and a lack of encystation in in
vitro axenic growth of E. histolytica HM-1:IMSS.
Based on genomic sequences, an EhACD role in amino acid catabolism for ATP
generation was postulated (5). Recently, Pineda et al. (31) reported amino acids do not
contribute to ATP production after exposing E. histolytica to PBS for 2 hours with and
without an amino acid source. Our growth data though showed a substantial reduction in
growth when tryptone was excluded , consistent with previous observation that mixture
of amino acids enhanced growth and survival of E. histolytica (6). No difference was
observed between growth of control cells (WT and LUC) and knockdown cells
(EhACKkd and EhACDkd) in tryptone excluded medium (Fig. 3.8A). Surprisingly,
EhACKkd cells showed enhanced growth in medium with both glucose and tryptone
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excluded (Fig. 3.8B). The molecular basis for this phenotype remains undefined but
suggests EhACK may possess a novel function.
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CONCLUSIONS:
Our results indicate that EhACD has a substantial role in proliferation of E.
histolytica on glucose and other growth substrates. EhACDkd cells exhibited a growth
defect in both normal and low serum TYI-S-33 media. Growth and metabolite data are
consistent with EhACD playing a role to extend glycolysis for ATP generation. The
substantial decreased of ATP pool in EhACDkd cells connects the growth defect to lack
of ATP availability. Likewise, EhACD showed evidence to be involved in utilizing
propionate for growth.
Our results also demonstrated a role for EhACK in growth. However, its role to
supply pyrophosphate for glycolysis proved to be unlikely. The molecular mechanism of
EhACK growth enhancement during amino acids and glucose starvation remains
undefined. Further analysis is warranted to elucidate EhACK’s in vivo function.
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CHAPTER IV
CONCLUSIONS AND FUTURE PROSPECTS
Acetate metabolism has attracted increasing attention due to its involvement in
tumorigenesis and metabolic disorders in humans and in pathogenesis. Typically, acetate
excretion and uptake are associated with energy metabolism and utilization as an
alternative carbon source. However, these pathways have also been linked to histone
acetylation and protein phosphorylation and thus, play a role in regulating gene
expression and activity. Therefore, it is of great interest to further explore these pathways
in depth.
Entamoeba histolytica is a human protozoan parasite which infects around 90
million people each year, causing approximately 50,000-100,000 deaths. Acetate is a
major metabolite produced by E. histolytica during growth on glucose that can be
generated by ACK and ACD (Figure 4.1). The role of these two enzymes in E. histolytica
metabolism has been the focus of this dissertation.
Physiological function of EhACK
Our results with antisense RNA mediated gene silencing revealed that ACK plays
a role in growth under different conditions. However, the data are not consistent with our
previously hypothesized role for ACK in providing pyrophosphate for glycolysis. An
ACK knockdown strain did show enhanced growth in medium in which glucose and
tryptone were omitted. This suggests ACK may possesses a novel role in E. histolytica
contrary to initial expectations.
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Currently, RNAseq is underway to characterize the molecular mechanism of the
ACK knockdown phenotype during growth in the absence of glucose and tryptone.
Metabolite analysis of this strain versus the WT under normal growth conditions and in
the absence of glucose and tryptone will be performed to determine whether intracellular
ATP or acetyl-CoA pools are affected. Determination of acetyl phosphate levels within E.
histolytica should also be undertaken. Acetyl phosphate measurements have previously
been done through either an enzyme assay or two-dimensional thin layer chromatography
(1-3)
. However, lability of acetyl phosphate can hinder accurate measurement. Since
EhACK prefers to catalyze the acetate-forming direction of the reaction, examining the
effects on intracellular acetyl phosphate concentrations remains an essential step in
understanding the physiological function of this enzyme.
Another question that has yet to be answered is what provides acetyl phosphate as
the substrate for ACK?  At the moment, known acetyl phosphate producing enzymes
have not been identified within E. histolytica. However, in 1954 Harting and Velick(4, 5)
showed evidence that glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from yeast
and rabbit catalyzes the formation of acetyl phosphate from acetaldehyde and inorganic
phosphate. GAPDH is a commonly associated glycolytic enzyme which converts
glyceraldehyde-3-phosphate to glycerate 1, 3-bisphosphate. E. histolytica possesses three
genes encoding GAPDH. Progress is underway to purify recombinant E. histolytica
GAPDH to examine whether it has the ability to produce acetyl phosphate.
Anthony and Spector (6) have previously shown that Escherichia coli ACK can be
phosphorylated by ATP or acetyl phosphate. A later study showed the E. coli ACK
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phosphoenzyme is catalytically active, being able to transfer the phosphate to ADP or
acetate (7). Following up on Anthony and Spector’s research, Fox et al. (8) found the ACK
phosphoenzyme can also transfer the phosphate to Enzyme I of Bacterial
phosphotransferase system. This evidence suggested ACK may have an alternative role
as a protein kinase. This possibility has not been investigated further. This raises the
intriguing question of whether EhACK role is as a protein kinase, possible in a regulatory
role involving protein phosphorylation. Additional investigation into whether EhACK
can be phosphorylated by PPi or acetyl phosphate and identifying potential
phosphorylation partners could lead to a better understanding of the in vivo role of this
enzyme.
Physiological function of EhACD
ACD gene silencing resulted in a reduction in growth compared to WT cells. This
was linked to a decrease of ATP pool in the ACD knockdown strain. The combination of
growth and metabolite analysis supported ACD’s hypothesized role to extend glycolysis
to increase ATP generation, as evidence by decreased growth, decreased intracellular
ATP concentration, and accumulation of acetyl-CoA.
ACD was also proposed to be able to activate acetate for utilization based on in
vitro kinetic analysis. Unexpectedly, wild-type E. histolytica was found to grow on
propionate but not acetate when glucose was absent from the medium. However, growth
on propionate was impeded in the ACD knockdown strain. This supports that ACD is
required for utilization of propionate as an alternative growth substrate in place of
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glucose. This is of physiological relevance since E. histolytica infects and inhabits a host
environment abundant in propionate.
Short chain fatty acids have been shown to influence Entamoeba invadens
encystation and histone acetylation (9-11). E. invadens is a close relative of E. histolytica
and infects and causes similar invasive infection in reptiles. ACD is present in E.
invadens, thus raising the question of whether ACD helped mediate these events.
Regrettably, E. histolytica exhibited undetectable levels of histone acetylation (11) and a
mechanism to induce encystation under laboratory conditions has not yet been
established. Thus, investigation into a role for ACD in encystation and histone acetylation
(as well as the resulting changes in gene regulation) cannot be performed in E. histolytica
at this time and should instead be followed up on in E. invadens.
Since E. histolytica was able to grow on propionate as a growth substrate in the
absence of glucose, metabolite labeling of E. histolytica grown on C13-propionate may
provide additional insights into propionate metabolism within this parasite. Additionally,
Ramakrishnan et al. (12) have developed a tetracycline inducible overexpression system
for E. histolytica. An ACD and ACK overexpression study will provide added
perspective in learning about the physiological role of these two enzymes.
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Figure 4.1: Representation of our current understanding of the physiological roles of
EhACK and EhACD in E. histolytica. The pathway shown is the extended glycolytic
pathway present in E. histolytica in which glucose is converted to pyruvate and then to
ethanol and acetate in the extended pathway. Dashed orange arrows embody the
previously hypothesized role for EhACK of providing pyrophosphate. The black boxes
with a question mark represent the unknown origin of acetyl phosphate and the fate of
propionyl-CoA. PPi-PFK: pyrophosphate dependent phosphofructokinase; PPDK:
pyruvate phosphate dikinase; ADHE: bifunctional aldehyde-alcohol dehydrogenase;
ACD: ADP-forming acetyl CoA synthetase; ACK: acetate kinase.
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Basis of EhACK phosphoryl substrate specificity
This research demonstrated E. histolytica ACK’s phosphoryl substrate specificity
is not solely dependent on substrate binding. Based on the structure, EhACK was found
to lack an adenosine pocket and utilizes Pi/PPi instead of ADP/ATP as for other ACKs.
This was attributed to having several bulkier amino acids blocking the entrance to the
adenosine pocket of EhACK. Even though opening the adenosine pocket did increase
ATP binding to the enzyme, it did not confer activity. Similarly, closure of entrance to
the M. thermophila ACK (MtACK) adenosine pocket did not force a phosphoryl
substrate switch to PPi.
Acetate kinase belongs to the acetate and sugar kinases/Hsc70/actin (ASKHA)
enzyme superfamily. Catalysis within this superfamily is characterized by domain
motion. Using tryptophan fluorescence quenching to study MtACK domain motion,
Gorrell and Ferry(13) showed only nucleotide binding caused domain closure. Further
analysis indicated that MtACK follows a half-site mechanism, where only half of the site
are bound to the ligand at any single moment.
Alterations that opened the EhACK adenosine pocket allowed ATP and ADP to
bind more effectively. However, it is unclear if this interaction stimulates domain motion
as would be necessary for enzymatic activity. Progress in this aspect will advance our
understanding of the nature of EhACK substrate specificity and will also improve our
understanding of ACK’s overall enzyme dynamics and catalytic mechanism.
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Currently, EhACK is the only known ACK able to utilize pyrophosphate and
inorganic phosphate as substrate. Identification of other PPi-dependent ACKs will aid in
our efforts to understand phosphoryl substrate selection and utilization by providing
additional amino acid sequences necessary to further identify unique features within PPi-
dependent ACK. Blast searches using EhACK as the query sequence identified four
hypothetical ACKs that share both bulkier amino acid residues within the ADENOSINE
motif and an extended PHOSPHATE2 motif with sequence identity and similarity
between 40-46% and 60-66%, respectively (Figure 3.7; refer to Chapter III for additional
details). Interestingly, ACK sequences that contain bulkier amino acids within the
ADENOSINE motif correspondingly possess an extended PHOSPHATE2 motif. Though
this correlation does not indicate that these are PPi-dependent ACK, this does warrant a
closer examination.
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APPENDIX
SUPPLEMENTAL INFORMATION
APPENDIX A: SUPPLEMENTAL FIGURES OF CHAPTER II
Figure A1. Inhibition curves for EhACK wild-type and variant enzymes. Enzymatic
activity was determined for each enzyme in the presence of the indicated concentration of
ADP, ATP, or PPi. Activities are plotted as a percentage of the activity observed for the
wild-type enzyme in the absence of inhibitor. Activities are the mean ± SD of three
replicates. (A) ADP inhibition in the acetate forming direction and (B) ATP inhibition in
the acetyl-phosphate-forming direction. Symbols for panels A-C: EhACK wild-type, (○);
EhACK Q323G-M324I variant (●); EhACK Q323A-M324A variant, (□); EhACK D272A-
R274A-Q323G-M324I variant (■) (except panel C). Symbols for panels D-E: MtACK wild-
type, (○); MtACK G331Q-I332M variant (●);
